UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 to
FORM 10-Q/A
(MARK ONE)
☒ QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the quarter ended June 30, 2021
☐ TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the transition period
from to
Commission file number: 001-40309
ACE
GLOBAL BUSINESS ACQUISITION LIMITED |
(Exact
Name of Registrant as Specified in Its Charter) |
British
Virgin Islands |
|
n/a |
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
6/F Unit B, Central 88,
88-89 Des Voeus Road Central
Central, Hong
Kong
(Address of principal executive offices)
(852) 9086
7042
(Issuer’s telephone number)
Securities registered pursuant to Section 12(b) of the Act:
Title
of Each Class |
|
Trading
Symbol |
|
Name
of Each Exchange on Which Registered |
Units,
each consisting of one Ordinary Share, par value $0.001 per share,
and one Redeemable Warrant entitling the holder to receive one
Ordinary Share |
|
ACBAU |
|
Nasdaq
Capital Market |
Ordinary
Shares |
|
ACBA |
|
Nasdaq
Capital Market |
Warrants |
|
ACBAW |
|
Nasdaq
Capital Market |
Check
whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☐
No ☒
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☐
No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company or an emerging growth company. See
definitions of “large accelerated filer”, “accelerated filer”,
“smaller reporting company”, and “emerging growth company” in
Rule 12b-2 of the Exchange Act.
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated
filer |
☒ |
Smaller
reporting company |
☒ |
|
Emerging
growth company |
☒ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). Yes ☒ No
☐
Indicate the number of shares outstanding of each of the
registrant’s classes of ordinary shares, as of the latest
practicable date: As of November 11, there were 6,054,000 ordinary
shares outstanding of the Registrant (assuming all of the units
issued in our initial public offering completed on April 8, 2021
were split on such date).
ACE GLOBAL BUSINESS ACQUISITION LIMITED
FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2021
TABLE OF CONTENTS
EXPLANATORY NOTE
References
throughout this Amendment No. 1 to the Quarterly Report on Form
10-Q/A to “we,” “us,” the “Company” or “our company” are to Ace
Global Business Acquisition Limited., unless the context otherwise
indicates.
This Amendment No. 1 to the Quarterly Report on Form 10-Q/A (this
“report”) amends the Quarterly Report on Form 10-Q of Ace Global
Business Acquisition Limited for the period ended June 30, 2021, as
filed with the Securities and Exchange Commission (“SEC”) on August
16, 2021 (the “Original Report”).
Background of Restatement
On April 12, 2021, the Acting Director of the Division of
Corporation Finance and Acting Chief Accountant of the SEC together
issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition
companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition
Companies(“SPACs”)” (the “SEC Statement”). Specifically, the SEC
Statement focused on certain provisions that provided for potential
changes to the settlement amounts dependent upon the
characteristics of the holder of the warrant, which terms are
similar to those contained in the warrant agreement governing the
Company’s warrants. As a result of the SEC Statement, on December
20, 2021, the Company reevaluated the accounting treatment of the
4,600,000 warrants that were issued to the Company’s public
shareholders in a public offering that closed concurrently with the
closing of the Initial Public Offering (the “Public Warrants”). The
Company previously accounted for the Public Warrants as components
of liabilities.
As a result of the above, the Company should have classified the
Public warrants as component of equity in its previously issued
financial statements. The Company’s accounting for the Public
warrants as components of equity instead of as derivative
liabilities did not have any effect on the Company’s previously
reported operating expenses or cash.
In addition, in accordance with the SEC and its staff’s guidance on
redeemable equity instruments, ASC Topic 480, Distinguishing
Liabilities from Equity (ASC 480), paragraph 10-S99, redemption
provisions not solely within the control of the Company require
ordinary share subject to redemption to be classified outside of
permanent equity. The Company had previously classified a portion
of its ordinary share in permanent equity. Although the Company did
not specify a maximum redemption threshold, its charter provides
that currently, the Company will not redeem its public shares in an
amount that would cause its net tangible assets to be less than
$5,000,001. On December 20, 2021, the Company determined that the
threshold would not change the nature of the underlying shares as
redeemable and thus would be required to be disclosed outside
equity. As a result, the Company’s previously issued (i) audited
balance sheet as of April 9, 2021 included in the Company’s Current
Report on Form 8-K/A filed with the SEC on May 19, 2021, (ii)
unaudited interim financial statements as of June 30, 2021 and for
the three and six months ended June 30, 2021 included in the
Company’s Quarterly Report on Form 10-Q filed with the SEC on
August 16, 2021 (collectively, the “Affected Periods”), in each
case, should be corrected to classify public warrants as equity and
all of the Public Shares as temporary equity and should no longer
be relied upon.
In connection with the restatement, the Company’s management
reassessed the effectiveness of its disclosure controls and
procedures for the periods affected by the restatement. As a result
of that reassessment, the Company’s management determined that its
disclosure controls and procedures for such periods were not
effective due to a material weakness in internal control over
financial reporting related to the classification of the Company’s
warrants as components of equity instead of as derivative
liabilities and the allocation and treatment of the initial
transaction costs of the initial public offering. For more
information, see Item 9A included in this Quarterly Report on
Form 10-Q/A.
The Company has reflected these corrections in its Quarterly Report
on Form 10-Q for the quarterly period ended September 30, 2021,
filed with SEC on November 16, 2021 (the “November 2021 Form 10-Q”)
and in this amended Quarterly Report on Form 10-Q/A for the period
ended September 30, 2021. The Company does not expect the changes
described above to have any impact on its cash position or the
balance held in the trust account. The Company has not amended its
previously filed Quarterly Reports on Form 10-Q or Current
Reports on Form 8-K for the period affected by the
restatement. The financial information that has been previously
filed or otherwise reported for these periods is superseded by the
information in this interim Report on Form 10-Q/A, and the
financial statements and related financial information contained in
such previously filed reports should no longer be relied upon.
The restatement is more fully described in Note 2 of the notes to
the financial statements included herein.
Items Amended in this Report
This report presents the Original Report, amended and restated with
modifications necessary to reflect the restatements, but without
any other amendments, modifications or updates. As such, this
report speaks only as of the date the Original Report was filed,
and should be read in conjunction with our other SEC filings,
including our SEC filings subsequent to the date of the Original
Report.
The following items have been amended to reflect the
restatements:
Part I, Item 1. Financial Statements And Supplementary Data
Part I, Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations
Part I, Item 4. Controls and Procedures
In addition, the Company’s Chief Executive Officer and Chief
Financial Officer have provided new certifications dated as of the
date of this filing in connection with this report (Exhibits 31.1,
31.2 and 32).
Except as described above, this Amendment No. 1 does not
amend, update or change any other items or disclosures in the
Original Filing and does not purport to reflect any information or
events subsequent to the filing thereof. As such, this Amendment
No. 1 speaks only as of the date the Original Filing was
filed, and we have not undertaken herein to amend, supplement or
update any information contained in the Original Filing to give
effect to any subsequent events. Accordingly, this Amendment
No. 1 should be read in conjunction with our filings made with
the SEC subsequent to the filing of the Original Filing, including
any amendment to those filings.
FORWARD LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, or the “Securities Act,” and Section 21E of the Securities
Exchange Act of 1934, or the Exchange Act. The statements contained
in this report that are not purely historical are forward-looking
statements. Our forward-looking statements include, but are not
limited to, statements regarding our or our management’s
expectations, hopes, beliefs, intentions or strategies regarding
the future. In addition, any statements that refer to projections,
forecasts or other characterizations of future events or
circumstances, including any underlying assumptions, are
forward-looking statements. The words “anticipates,” “believe,”
“continue,” “could,” “estimate,” “expect,” “intends,” “may,”
“might,” “plan,” “possible,” “potential,” “predicts,” “project,”
“should,” “would” and similar expressions may identify
forward-looking statements, but the absence of these words does not
mean that a statement is not forward-looking. Forward-looking
statements in this Form 10-Q may include, for example, statements
about our:
|
● |
ability
to complete our initial business combination; |
|
● |
success in retaining or recruiting, or changes required in, our
officers, key employees or directors following
our initial business combination;
|
|
● |
officers
and directors allocating their time to other businesses and
potentially having conflicts of interest with our business or in
approving our initial business combination, as a result of which
they would then receive expense reimbursements; |
|
● |
potential
ability to obtain additional financing to complete a business
combination; |
|
● |
pool
of prospective target businesses; |
|
● |
ability
of our officers and directors to generate a number of potential
investment opportunities; |
|
● |
potential
change in control if we acquire one or more target businesses for
shares; |
|
● |
public
securities’ potential liquidity and trading; |
|
● |
the
lack of a market for our securities; |
|
● |
expectations
regarding the time during which we will be an “emerging growth
company” under the JOBS Act; |
|
● |
use
of proceeds not held in the trust account or available to us from
interest income on the trust account balance; or |
|
● |
financial
performance following our IPO. |
The forward-looking statements contained in this Form 10-K are
based on our current expectations and beliefs concerning future
developments and their potential effects on us. There can be no
assurance that future developments affecting us will be those that
we have anticipated. These forward-looking statements involve a
number of risks, uncertainties (some of which are beyond our
control) or other assumptions that may cause actual results or
performance to be materially different from those expressed or
implied by these forward-looking statements. Should one or more of
these risks or uncertainties materialize, or should any of our
assumptions prove incorrect, actual results may vary in material
respects from those projected in these forward-looking statements.
We undertake no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as may be required under applicable securities
laws.
PART I - FINANCIAL INFORMATION
ACE GLOBAL BUSINESS ACQUISITION LIMITED
UNAUDITED CONDENSED BALANCE SHEETS
|
|
June 30,
2021 |
|
|
December 31,
2020 |
|
|
|
(Restated) |
|
|
|
|
ASSETS |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
812,369 |
|
|
$ |
-
|
|
Prepayment |
|
|
182,134 |
|
|
|
-
|
|
Deferred offering costs |
|
|
-
|
|
|
|
45,000 |
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
994,503 |
|
|
|
45,000 |
|
Cash and investments held in trust account |
|
|
46,921,335 |
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
47,915,838 |
|
|
$ |
45,000 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accrued liabilities and other payable |
|
$ |
8,903 |
|
|
$ |
2,967 |
|
Advances from a related party |
|
|
327,839 |
|
|
|
32,839 |
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
336,742 |
|
|
|
35,806 |
|
|
|
|
|
|
|
|
|
|
Warrant liabilities |
|
|
1,250,000 |
|
|
|
-
|
|
Deferred underwriting compensation |
|
|
1,840,000 |
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES |
|
|
3,426,742 |
|
|
|
35,806 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Ordinary shares, subject to redemption 4,600,000 and 0 shares (at
conversion value of $10.20 and $0 per share) |
|
|
46,920,000 |
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Shareholders’ (deficit) equity: |
|
|
|
|
|
|
|
|
Ordinary shares, $0.001 par value; 100,000,000 shares authorized;
1,454,000 and 1,150,000 shares issued and outstanding (excluding
4,600,000 and 0 shares subject to redemption) |
|
|
1,454 |
|
|
|
1,150 |
|
Additional paid-in capital |
|
|
-
|
|
|
|
23,850 |
|
Accumulated deficit |
|
|
(2,432,358 |
) |
|
|
(15,806 |
) |
|
|
|
|
|
|
|
|
|
Total shareholders’ (deficit) equity |
|
|
(2,430,904 |
) |
|
|
9,194 |
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
|
$ |
47,915,838 |
|
|
$ |
45,000 |
|
See accompanying notes to unaudited condensed financial
statements.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
UNAUDITED CONDENSED STATEMENT OF OPERATIONS
|
|
Three months
ended
June 30, |
|
|
Six months
ended
June 30, |
|
|
|
2021 |
|
|
2021 |
|
|
|
(Restated) |
|
|
(Restated) |
|
|
|
|
|
|
|
|
Formation, general and administrative expenses |
|
$ |
(250,360 |
) |
|
$ |
(346,457 |
) |
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
(250,360 |
) |
|
|
(346,457 |
) |
|
|
|
|
|
|
|
|
|
Other income |
|
|
|
|
|
|
|
|
Change fair value of warrant liabilities |
|
|
8,560 |
|
|
|
8,560 |
|
Dividend income |
|
|
1,335 |
|
|
|
1,335 |
|
Interest income |
|
|
22 |
|
|
|
24 |
|
Total other income, net |
|
|
9,917 |
|
|
|
9,919 |
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(240,443 |
) |
|
|
(336,538 |
) |
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
NET LOSS |
|
|
(240,443 |
) |
|
|
(336,538 |
) |
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, common stock
subject to possible redemption |
|
|
4,145,055 |
|
|
|
2,083,978 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income (loss) per share, common stock subject
to possible redemption |
|
|
0.27 |
|
|
|
0.82 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding , common
stock attributable to Ace Global Business Acquisition Limited |
|
|
1,423,934 |
|
|
|
1,287,724 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per share, common stock attributable to
Ace Global Business Acquisition Limited |
|
|
(0.94 |
) |
|
|
(1.59 |
) |
See accompanying notes to unaudited condensed financial
statements.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’
EQUITY
|
|
Six months
ended June 30, 2021 |
|
|
|
Ordinary
shares |
|
|
Additional
paid-in |
|
|
Accumulated |
|
|
Total
shareholders’ |
|
|
|
No. of shares |
|
|
Amount |
|
|
capital |
|
|
deficit |
|
|
equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2021 |
|
|
1,150,000 |
|
|
$ |
1,150 |
|
|
$ |
23,850 |
|
|
$ |
(15,806 |
) |
|
$ |
9,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale
of units in initial public offering |
|
|
4,600,000 |
|
|
|
4,600 |
|
|
|
43,030,400 |
|
|
|
-
|
|
|
|
43,035,000 |
|
Sale
of units to the founder in private placement |
|
|
304,000 |
|
|
|
304 |
|
|
|
1,781,136 |
|
|
|
-
|
|
|
|
1,781,440 |
|
Initial classification of ordinary shares subject to possible
redemption |
|
|
(4,600,000 |
) |
|
|
(4,600 |
) |
|
|
(44,787,763 |
) |
|
|
-
|
|
|
|
(44,792,363 |
) |
Allocation of offering costs to common stock subject to
redemption |
|
|
- |
|
|
|
-
|
|
|
|
2,887,160 |
|
|
|
-
|
|
|
|
2,887,160 |
|
Accretion of
carrying value to redemption value |
|
|
- |
|
|
|
-
|
|
|
|
(2,934,783 |
) |
|
|
(2,080,014 |
) |
|
|
(5,014,797 |
) |
Net loss |
|
|
- |
|
|
|
-
|
|
|
|
-
|
|
|
|
(336,538 |
) |
|
|
(336,538 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of June 30, 2021 (Restated) |
|
|
1,454,000 |
|
|
$ |
1,454 |
|
|
$ |
-
|
|
|
$ |
(2,432,358 |
) |
|
$ |
(2,430,904 |
) |
|
|
Three months
ended June 30, 2021 |
|
|
|
Ordinary
shares |
|
|
Additional
paid-in |
|
|
Accumulated |
|
|
Total
shareholders’ |
|
|
|
No. of shares |
|
|
Amount |
|
|
capital |
|
|
deficit |
|
|
equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of April 1, 2021 |
|
|
1,150,000 |
|
|
$ |
1,150 |
|
|
$ |
23,850 |
|
|
$ |
(111,901 |
) |
|
$ |
(86,901 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale
of units in initial public offering |
|
|
4,600,000 |
|
|
|
4,600 |
|
|
|
43,030,400 |
|
|
|
-
|
|
|
|
43,035,000 |
|
Sale
of units to the founder in private placement |
|
|
304,000 |
|
|
|
304 |
|
|
|
1,781,136 |
|
|
|
-
|
|
|
|
1,781,440 |
|
Initial classification of ordinary shares subject to possible
redemption |
|
|
(4,600,000 |
) |
|
|
(4,600 |
) |
|
|
(44,787,763 |
) |
|
|
-
|
|
|
|
(44,792,363 |
) |
Allocation of offering costs to common stock subject to
redemption |
|
|
- |
|
|
|
-
|
|
|
|
2,887,160 |
|
|
|
-
|
|
|
|
2,887,160 |
|
Accretion of
carrying value to redemption value |
|
|
- |
|
|
|
-
|
|
|
|
(2,934,783 |
) |
|
|
(2,080,014 |
) |
|
|
(5,014,797 |
) |
Net loss |
|
|
- |
|
|
|
-
|
|
|
|
-
|
|
|
|
(240,443 |
) |
|
|
(240,443 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of June 30, 2021 (Restated) |
|
|
1,454,000 |
|
|
$ |
1,454 |
|
|
$ |
-
|
|
|
$ |
(2,432,358 |
) |
|
$ |
(2,430,904 |
) |
See accompanying notes to unaudited condensed financial
statements.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS
|
|
Six
months
ended
June 30,
2021 |
|
|
|
(Restated) |
|
Cash flows from operating
activities |
|
|
|
Net loss |
|
$ |
(336,538 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities |
|
|
|
|
Change in fair value of warrant liabilities |
|
|
(8,560 |
) |
Interest income and dividend income earned in cash and investments
income held in trust account |
|
|
(1,335 |
) |
|
|
|
|
|
Change in operating assets and liabilities: |
|
|
|
|
Increase in prepayment |
|
|
(182,134 |
) |
Increase in accrued liabilities |
|
|
5,936 |
|
|
|
|
|
|
Net cash used in operating activities |
|
|
(522,631 |
) |
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Proceeds deposited in Trust Account |
|
|
(46,920,000 |
) |
|
|
|
|
|
Net cash used in investing activities |
|
|
(46,920,000 |
) |
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
Proceeds from public offering |
|
|
44,920,000 |
|
Proceeds from private placements to a related party |
|
|
3,040,000 |
|
Advances from a related party |
|
|
295,000 |
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
48,255,000 |
|
|
|
|
|
|
Net change in cash |
|
|
812,369 |
|
|
|
|
|
|
Cash, beginning of period |
|
|
-
|
|
|
|
|
|
|
Cash, end of period |
|
$ |
812,369 |
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING
ACTIVITIES:
Initial classification of ordinary shares subject to possible
redemption |
|
$ |
44,792,363 |
|
Allocation of
offering costs to common stock subject to redemption |
|
$ |
2,887,160 |
|
Accretion of carrying value to
redemption value |
|
|
(5,014,797 |
) |
Accrued
underwriting compensation |
|
$ |
1,840,000 |
|
Initial
recognition of warrant liabilities |
|
$ |
1,258,560 |
|
See accompanying notes to unaudited condensed financial
statements.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 1 – ORGANIZATION AND BUSINESS BACKGROUND
Ace Global Business Acquisition Limited (the “Company”) is a newly
organized blank check company incorporated on November 2, 2020,
under the laws of the British Virgin Islands for the purpose of
acquiring, engaging in a share exchange, share reconstruction and
amalgamation, purchasing all or substantially all of the assets of,
entering into contractual arrangements, or engaging in any other
similar business combination with one or more businesses or
entities (Business Combination”). Although the Company is not
limited to a particular industry or geographic region for purposes
of consummating a Business Combination, the Company intends to
focus on opportunities in the artificial intelligence and any other
related technology innovations market in North America.
As of June 30, 2021, the Company had not commenced any operations.
All activity through June 30, 2021 relates to the Company’s
formation and the initial public offering as described below. The
Company has selected December 31 as its fiscal year end.
Financing
The registration statement for the Company’s Initial Public
Offering became effective on April 5, 2021. On April 8, 2021, the
Company consummated the Initial Public Offering of 4,000,000 units
(the “Public Units”), at $10.00 per Public Unit, generating gross
proceeds of $40,000,000 which is described in Note 3.
Subsequently, the underwriters exercised their over-allotment
option in full, and the closing of the issuance and sale of the
additional Public Units occurred on April 9, 2021. The total
aggregate issuance by the Company of 600,000 units at a price of
$10.00 per unit resulted in gross proceeds of $6,000,000.
Simultaneously with the closing of the Initial Public Offering on
April 8, 2021, the Company consummated the sale of 280,000 units
(the “Private Units”) at a price of $10.00 per Private Unit in a
private placement, generating gross proceeds of $2,800,000, which
is described in Note 6. On April 9, 2021, simultaneously with the
sale of the over-allotment units, the Company consummated the
private sale of an additional 24,000 Private Units, generating
gross proceeds of $240,000.
Transaction costs amounted to $1,125,000, consisting of $920,000 of
underwriter’s fees and $205,000 of other offering costs.
Trust Account
Following the closing of the Initial Public Offering on April 8,
2021 and exercise of the over-allotment option on April 9, 2021, an
aggregate amount of $46,920,000 from the net proceeds of the sale
of the Public Units in the Initial Public Offering and the sale of
the Private Placement Units was placed in a trust account (the
“Trust Account”). The aggregate amount of $46,920,000 ($10.20 per
Public Unit) will be invested in U.S. government securities, within
the meaning set forth in Section 2(a)(16) of the Investment
Company Act, with a maturity of 185 days or less, or in any
open-ended investment company that holds itself out as a money
market fund meeting certain conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the
earlier of: (i) the completion of a Business Combination and
(ii) the distribution of the funds in the Trust Account to the
Company’s shareholders, as described below, except that interest
earned on the Trust Account can be released to the Company to pay
its tax obligations.
Business Combination
The Company’s management has broad discretion with respect to the
specific application of the net proceeds of the Initial Public
Offering and sale of the Private Units, although substantially all
of the net proceeds are intended to be applied generally toward
consummating a Business Combination. NASDAQ rules provide that the
Business Combination must be with one or more target businesses
that together have a fair market value equal to at least 80% of the
balance in the Trust Account (as defined below) (less any deferred
underwriting commissions and taxes payable on interest earned) at
the time of the signing of an agreement to enter into a Business
Combination. The Company will only complete a Business Combination
if the post-Business Combination company owns or acquires 50% or
more of the outstanding voting securities of the target or
otherwise acquires a controlling interest in the target sufficient
for it not to be required to register as an investment company
under the Investment Company Act of 1940, as amended (the
“Investment Company Act”). There is no assurance that the Company
will be able to successfully effect a Business Combination.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The Company will provide its shareholders with the opportunity to
redeem all or a portion of their Public Shares upon the completion
of a Business Combination either (i) in connection with a
shareholder meeting called to approve the Business Combination or
(ii) by means of a tender offer. In connection with an Initial
Business Combination, the Company may seek shareholder approval of
a Business Combination at a meeting called for such purpose at
which shareholders may seek to redeem their shares, regardless of
whether they vote for or against a Business Combination. The
Company will proceed with a Business Combination only if the
Company has net tangible assets of at least $5,000,001 upon such
consummation of a Business Combination and, if the Company seeks
shareholder approval, a majority of the outstanding shares voted
are voted in favor of the Business Combination.
If a shareholder vote is not required and the Company does not
decide to hold a shareholder vote for business or other legal
reasons, the Company will, pursuant to its Amended and Restated
Memorandum and Articles of Association, offer such redemption
pursuant to the tender offer rules of the Securities and Exchange
Commission (“SEC”), and file tender offer documents containing
substantially the same information as would be included in a proxy
statement with the SEC prior to completing a Business
Combination.
The shareholders will be entitled to redeem their Public Shares for
a pro rata portion of the amount then in the Trust Account
(initially $10.20 per Public Share, subject to increase of up to an
additional $0.10 per Public Share in the event that the Ace Global
Investment Limited, the sponsor elects to extend the period of time
to consummate a Business Combination (see below), plus any pro rata
interest earned on the funds held in the Trust Account and not
previously released to the Company to pay its tax obligations). The
per-share amount to be distributed to shareholders who redeem their
Public Shares will not be reduced by the deferred underwriting
commissions the Company will pay to the underwriter (as discussed
in Note 10). There will be no redemption rights upon the completion
of a Business Combination with respect to the Company’s rights or
warrants. The ordinary shares will be recorded at redemption value
and classified as temporary equity upon the completion of the
Initial Public Offering, in accordance with Accounting Standards
Codification (“ASC”) Topic 480 “Distinguishing Liabilities from
Equity.”
The sponsor and any of the Company’s officers or directors that may
hold Founder Shares (as defined in Note 5) (the “shareholders”) and
the underwriters will agree (a) to vote their Founder Shares, the
ordinary shares included in the Private Units (the “Private
Shares”) and any Public Shares purchased during or after the
Initial Public Offering in favor of a Business Combination, (b) not
to propose an amendment to the Company’s Amended and Restated
Memorandum and Articles of Association with respect to the
Company’s pre-Business Combination activities prior to the
consummation of a Business Combination unless the Company provides
dissenting public shareholders with the opportunity to redeem their
Public Shares in conjunction with any such amendment; (c) not to
redeem any shares (including the Founder Shares) and Private Shares
into the right to receive cash from the Trust Account in connection
with a shareholder vote to approve a Business Combination (or to
sell any shares in a tender offer in connection with a Business
Combination if the Company does not seek shareholder approval in
connection therewith) or a vote to amend the provisions of the
Amended and Restated Memorandum and Articles of Association
relating to shareholders’ rights of pre-Business Combination
activity and (d) that the Founder Shares and Private Shares shall
not participate in any liquidating distributions upon winding up if
a Business Combination is not consummated. However, the
shareholders will be entitled to liquidating distributions from the
Trust Account with respect to any Public Shares purchased during or
after the Initial Public Offering if the Company fails to complete
its Business Combination.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The Company will have until April 8, 2022 to consummate a Business
Combination. However, if the Company anticipates that it may not be
able to consummate a Business Combination within 12 months, the
Company may extend the period of time to consummate a Business
Combination up to three times, each by an additional three months
(for a total of 21 months to complete a Business Combination (the
“Combination Period”). In order to extend the time available for
the Company to consummate a Business Combination, the sponsor or
its affiliate or designees must deposit into the Trust Account
$455,400 (approximately $0.099 per Public Share), on or prior to
the date of the applicable deadline, for each three months
extension. Any funds which may be provided to extend the time frame
will be in the form of a loan to us from our sponsor. The terms of
any such loan have not been definitely negotiated, provided,
however, any loan will be interest free and will be repayable only
if the Company compete a business combination.
Liquidation
If the Company is unable to complete a Business Combination within
the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as
reasonably possible but no more than ten business days thereafter,
redeem 100% of the outstanding Public Shares, at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in
the Trust Account, including interest earned (net of taxes
payable), which redemption will completely extinguish public
shareholders’ rights as shareholders (including the right to
receive further liquidation distributions, if any), subject to
applicable law, and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of the remaining
shareholders and the Company’s board of directors, proceed to
commence a voluntary liquidation and thereby a formal dissolution
of the Company, subject in each case to its obligations to provide
for claims of creditors and the requirements of applicable law. The
underwriters have agreed to waive its rights to the deferred
underwriting commission held in the Trust Account in the event the
Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be
included with the funds held in the Trust Account that will be
available to fund the redemption of the Public Shares. In the event
of such distribution, it is possible that the per share value of
the assets remaining available for distribution will be less than
$10.00.
The sponsor has agreed that it will be liable to the Company, if
and to the extent any claims by a vendor for services rendered or
products sold to the Company, or a prospective target business with
which the Company has discussed entering into a transaction
agreement, reduce the amounts in the Trust Account to below $10.00
per share (whether or not the underwriters’ over-allotment option
is exercised in full), except as to any claims by a third party who
executed a waiver of any and all rights to seek access to the Trust
Account and except as to any claims under the Company’s indemnity
of the underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act of
1933, as amended (the “Securities Act”). In the event that an
executed waiver is deemed to be unenforceable against a third
party, the sponsor will not be responsible to the extent of any
liability for such third party claims. The Company will seek to
reduce the possibility that the sponsor will have to indemnify the
Trust Account due to claims of creditors by endeavoring to have all
vendors, service providers, prospective target businesses or other
entities with which the Company does business, execute agreements
with the Company waiving any right, title, interest or claim of any
kind in or to monies held in the Trust Account.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 2 – RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL
STATEMENTS
On April 12, 2021, the Acting Director of the Division of
Corporation Finance and Acting Chief Accountant of the SEC together
issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition
companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition
Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC
Statement focused on certain provisions that provided for potential
changes to the settlement amounts dependent upon the
characteristics of the holder of the warrant, which terms are
similar to those contained in the warrant agreement governing the
Company’s warrants.
The Company’s management evaluated the warrants under Accounting
Standards Codification (“ASC”) Subtopic 815-40, Contracts in
Entity’s Own Equity. ASC Section 815-40-15 addresses
equity versus liability treatment and classification of
equity-linked financial instruments, including warrants, and states
that a warrant may be classified as a component of equity only if,
among other things, the warrant is indexed to the issuer’s common
stock. Under ASC Section 815-40-15, a warrant is not
indexed to the issuer’s common stock if the terms of the warrant
require an adjustment to the exercise price upon a specified event
and that event is not an input to the fair value of the warrant.
The Company’s Private Warrants are not indexed to the Company’s
common shares in the manner contemplated by ASC
Section 815-40-15 because the holder of the instrument is not
an input into the pricing of a fixed-for-fixed option on equity
shares. In addition, the tender offer provision included in the
warrant agreement fails the “classified in shareholders’ equity”
criteria as contemplated by ASC Section 815-40-25. As a
result, the only Private Warrants shall be classified as
liabilities and the Public Warrants shall be classified as equity
and the Company reevaluated the accounting treatment of the
4,600,000 warrants that were issued to the Company’s sponsor
in an initial public offering (“Public Warrants”). The Company
previously accounted for the Public Warrants as components of
liabilities.
In further consideration of the guidance in Accounting Standards
Codification (“ASC”) 815-40, Derivatives and Hedging — Contracts in
Entity’s Own Equity (“ASC 815”), the Company concluded that a
provision in the warrant agreement related to certain transfer
provisions precludes the Private Warrants from being accounted for
as components of equity. As the Private Warrants meet the
definition of a derivative as contemplated in ASC 815, the Private
Warrants should be recorded as derivative liabilities on the
balance sheet and measured at fair value at inception (on the date
of the Initial Public Offering) and at each reporting date in
accordance with ASC 820, Fair Value Measurement, with changes in
fair value recognized in the Statements of Operations in the period
of change.
In Addition, the Company also concluded it should revise its
consolidated financial statements to classify all common stock
subject to possible redemption in temporary equity. In accordance
with the SEC and its staff’s guidance on redeemable equity
instruments, ASC Topic 480, Distinguishing Liabilities from
Equity (ASC 480), paragraph 10-S99, redemption provisions not
solely within the control of the Company require common stock
subject to redemption to be classified outside of permanent equity.
The Company had previously classified a portion of its common stock
in permanent equity. Although the Company did not specify a maximum
redemption threshold, its charter provides that currently, the
Company will not redeem its public shares in an amount that would
cause its net tangible assets to be less than $5,000,001. The
Company considered that the threshold would not change the nature
of the underlying shares as redeemable and thus would be required
to be disclosed outside equity. As a result, the Company revised
its previously filed financial statements to classify all common
stock as temporary equity and to recognize accretion from the
initial book value to redemption value at the time of its Initial
Public Offering and in accordance with ASC 480. The change in the
carrying value of redeemable shares of common stock resulted in
charges against additional paid-in capital and accumulated
deficit.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The following tables summarize the effect of the revision on each
financial statement line item as of the dates, and for the period,
indicated:
Adjustment #1 refer to reclassification of public warrants from
warrant liabilities to equity component.
Adjustment #2 refer to reclassification of all public shares to
temporary equity.
|
|
As
Previously
Reported |
|
|
Adjustments #1 |
|
|
Adjustments #2 |
|
|
As
Restated |
|
Balance sheet as of April 9,
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities |
|
|
14,506,560 |
|
|
|
(13,248,000 |
) |
|
|
-
|
|
|
|
1,258,560 |
|
Total liabilities |
|
|
16,690,334 |
|
|
|
(13,248,000 |
) |
|
|
-
|
|
|
|
3,442,334 |
|
Ordinary shares subject to possible
redemption |
|
|
26,405,954 |
|
|
|
-
|
|
|
|
20,514,046 |
|
|
|
46,920,000 |
|
Ordinary shares |
|
|
3,465 |
|
|
|
-
|
|
|
|
(2,011 |
) |
|
|
1,454 |
|
Additional paid-in capital |
|
|
5,184,021 |
|
|
|
13,248,000 |
|
|
|
(18,433,320 |
) |
|
|
-
|
|
Accumulated deficit |
|
|
(187,479 |
) |
|
|
-
|
|
|
|
(2,080,014 |
) |
|
|
(2,267,493 |
) |
Total shareholders’ equity (deficit) |
|
|
5,000,007 |
|
|
|
13,248,000 |
|
|
|
(20,514,046 |
) |
|
|
(2,266,039 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet as of June 30, 2021
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares subject to possible
redemption |
|
|
39,489,087 |
|
|
|
-
|
|
|
|
7,430,913 |
|
|
|
46,920,000 |
|
Ordinary shares |
|
|
2,183 |
|
|
|
-
|
|
|
|
(729 |
) |
|
|
1,454 |
|
Additional paid-in capital |
|
|
5,350,170 |
|
|
|
-
|
|
|
|
(5,350,170 |
) |
|
|
-
|
|
Accumulated deficit |
|
|
(352,344 |
) |
|
|
-
|
|
|
|
(2,080,014 |
) |
|
|
(2,432,358 |
) |
Total shareholders’ equity (deficit) |
|
|
5,000,009 |
|
|
|
-
|
|
|
|
(7,430,913 |
) |
|
|
(2,430,904 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of operations for the three months
ended June 30, 2021 (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares
outstanding, ordinary stock subject to possible
redemption |
|
|
-
|
|
|
|
-
|
|
|
|
4,145,055 |
|
|
|
4,145,055 |
|
Basic and diluted income per share, ordinary
share subject to possible redemption |
|
|
-
|
|
|
|
-
|
|
|
|
0.27 |
|
|
|
0.27 |
|
Basic and diluted weighted average shares
outstanding, Non-redeemable ordinary shares |
|
|
2,065,838 |
|
|
|
-
|
|
|
|
(641,904 |
) |
|
|
1,423,934 |
|
Basic and diluted net loss per share,
non-redeemable ordinary shares |
|
|
(0.12 |
) |
|
|
-
|
|
|
|
(0.82 |
) |
|
|
(0.94 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the six months
ended June 30, 2021 (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares
outstanding, ordinary stock subject to possible
redemption |
|
|
-
|
|
|
|
-
|
|
|
|
2,083,978 |
|
|
|
2,083,978 |
|
Basic and diluted net (loss) income per share,
ordinary share subject to possible redemption |
|
|
-
|
|
|
|
-
|
|
|
|
0.82 |
|
|
|
0.82 |
|
Basic and diluted weighted average shares
outstanding, Non-redeemable ordinary shares |
|
|
1,610,449 |
|
|
|
-
|
|
|
|
(322,725 |
) |
|
|
1,287,724 |
|
Basic and diluted net loss per share,
non-redeemable ordinary shares |
|
|
(0.21 |
) |
|
|
-
|
|
|
|
(1.38 |
) |
|
|
(1.59 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the six months
ended June 30, 2021 (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial classification of shares subject to
conversion |
|
|
39,653,959 |
|
|
|
-
|
|
|
|
5,138,404 |
|
|
|
44,792,363 |
|
Change in value of shares subject to
conversion |
|
|
(164,872 |
) |
|
|
-
|
|
|
|
164,872 |
|
|
|
-
|
|
Allocation of offering costs to common stock
subject to redemption |
|
|
-
|
|
|
|
-
|
|
|
|
2,887,160 |
|
|
|
2,887,160 |
|
Accretion of carrying value to redemption
value |
|
|
-
|
|
|
|
-
|
|
|
|
(5,014,797 |
) |
|
|
(5,014,797 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Changes In Shareholders’ Deficit
for the three months ended June 30, 2021
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial classification of shares subject to
conversion – ordinary shares – no. of shares |
|
|
(3,887,643 |
) |
|
|
-
|
|
|
|
(712,357 |
) |
|
|
(4,600,000 |
) |
Initial classification of shares subject to
conversion – ordinary shares – amount |
|
|
(3,888 |
) |
|
|
-
|
|
|
|
(712 |
) |
|
|
(4,600 |
) |
Initial classification of shares subject to
conversion – additional paid-in capital |
|
|
(39,650,071 |
) |
|
|
-
|
|
|
|
(5,137,692 |
) |
|
|
(44,787,763 |
) |
Initial classification of shares subject to
conversion – total shareholder’s deficit |
|
|
(39,653,959 |
) |
|
|
-
|
|
|
|
(5,138,404 |
) |
|
|
(44,792,363 |
) |
Allocation of offering costs to common stock
subject to redemption |
|
|
2,887,160 |
|
|
|
-
|
|
|
|
2,887,160 |
|
|
|
2,887,160 |
|
Accretion of carrying value to redemption
value |
|
|
(2,934,783 |
) |
|
|
-
|
|
|
|
(2,934,783 |
) |
|
|
(2,934,783 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Changes In Shareholders’ Deficit
for the six months ended June 30, 2021 (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial classification of shares subject to
conversion – ordinary shares – no. of shares |
|
|
(3,887,643 |
) |
|
|
-
|
|
|
|
(712,357 |
) |
|
|
(4,600,000 |
) |
Initial classification of shares subject to
conversion – ordinary shares – amount |
|
|
(3,888 |
) |
|
|
-
|
|
|
|
(712 |
) |
|
|
(4,600 |
) |
Initial classification of shares subject to
conversion – additional paid-in capital |
|
|
(39,650,071 |
) |
|
|
-
|
|
|
|
(5,137,692 |
) |
|
|
(44,787,763 |
) |
Initial classification of shares subject to
conversion – total shareholder’s deficit |
|
|
(39,653,959 |
) |
|
|
-
|
|
|
|
(5,138,404 |
) |
|
|
(44,792,363 |
) |
Allocation of offering costs to common stock
subject to redemption |
|
|
2,887,160 |
|
|
|
-
|
|
|
|
2,887,160 |
|
|
|
2,887,160 |
|
Accretion of carrying value to redemption
value |
|
|
(2,934,783 |
) |
|
|
-
|
|
|
|
(2,934,783 |
) |
|
|
(2,934,783 |
) |
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES
● Basis of
presentation
These accompanying financial statements have been prepared in
accordance with generally accepted accounting principles in the
United States of America (“U.S. GAAP”) and pursuant to the rules
and regulations of the Securities and Exchange Commission (“SEC”).
The interim financial information provided is unaudited, but
includes all adjustments which management considers necessary for
the fair presentation of the results for these periods. Operating
results for the interim period ended June 30, 2021 are not
necessarily indicative of the results that may be expected for the
fiscal year ending December 31, 2021. The information included in
this Form 10-Q/A should be read in conjunction with Management’s
Discussion and Analysis, and the financial statements and notes
thereto included in the Company’s Form S-1 for the fiscal year
ended December 31, 2020, filed with the SEC on January 22,
2021.
● Emerging growth company
The Company is an “emerging growth company,” as defined in Section
2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take
advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm
attestation requirements of Section 404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in
its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute
payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised
financial accounting standards until private companies (that is,
those that have not had a Securities Act registration statement
declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or
revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth
companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition
period which means that when a standard is issued or revised and it
has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or
revised standard at the time private companies adopt the new or
revised standard. This may make comparison of the Company’s
financial statements with another public company which is neither
an emerging growth company nor an emerging growth company which has
opted out of using the extended transition period difficult or
impossible because of the potential differences in accounting
standards used.
● Use of
estimates
In preparing these financial statements in conformity with U.S.
GAAP, management makes estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported expenses during the reporting
period.
Making estimates requires management to exercise significant
judgment. It is at least reasonably possible that the estimate of
the effect of a condition, situation or set of circumstances that
existed at the date of the financial statements, which management
considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly,
Actual results may differ from these estimates.
● Cash
The Company considers all short-term investments with an original
maturity of three months or less when purchased to be cash
equivalents. The Company did not have any cash equivalents as of
June 30, 2021 and December 31, 2020.
● Cash and investment held in trust account
At June 30, 2021, the assets held in the Trust Account are held in
cash and US Treasury securities . Investment securities in the
Company’s Trust Account consisted of $46,921,322 in United States
Treasury Bills and $13 in cash.
The Company classifies marketable securities as available-for-sale
at the time of purchase and reevaluates such classification as of
each balance sheet date. All marketable securities are recorded at
their estimated fair value. Unrealized gains and losses for
available-for-sale securities are recorded in other comprehensive
income. The Company evaluates its investments to assess whether
those with unrealized loss positions are other than temporarily
impaired. Impairments are considered other than temporary if they
are related to deterioration in credit risk or if it is likely the
Company will sell the securities before the recovery of the cost
basis. Realized gains and losses and declines in value determined
to be other than temporary are determined based on the specific
identification method and are reported in other income (expense),
net in the statements of operations.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
● Deferred
Offering Costs
Deferred offering costs consist of underwriting, legal, accounting
and other expenses incurred through the balance sheet date that are
directly related to the Initial public Offering and that were
charged to shareholders’ equity upon the completion of the Initial
Public Offering.
● Warrant
liabilities
The Company accounts for the Warrants in accordance with the
guidance contained in ASC 815-40-15-7D and 7F under which the
Private Warrants do not meet the criteria for equity treatment and
must be recorded as liabilities. Accordingly, the Company
classifies the Private Warrants as liabilities at their fair value
and adjusts the Private Warrants to fair value at each reporting
period. This liability is subject to re-measurement at each balance
sheet date until exercised, and any change in fair value is
recognized in our statement of operations. The Private Warrants are
valued using a Black Scholes model.
● Ordinary
shares subject to possible redemption
The Company accounts for its ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480
“Distinguishing Liabilities from Equity.” Ordinary share
subject to mandatory redemption (if any) is classified as a
liability instrument and is measured at fair value. Conditionally
redeemable ordinary shares (including ordinary shares that feature
redemption rights that are either within the control of the holder
or subject to redemption upon the occurrence of uncertain events
not solely within the Company’s control) are classified as
temporary equity. At all other times, ordinary shares are
classified as shareholders’ equity. As of June 30, 2021, 4,600,000
ordinary shares subject to possible redemption which are subject to
occurrence of uncertain future events and considered to be outside
of the Company’s control are presented as temporary equity, outside
of the shareholders’ equity section of the Company’s balance
sheet.
● Offering
costs
The Company complies with the requirements of the ASC 340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses
of Offering”. Offering costs consist principally of
professional and registration fees incurred through the balance
sheet date that are related to the Public Offering and that were
charged to shareholders’ equity upon the completion of the Public
Offering.
● Fair
value of financial instruments
FASB ASC Topic 820 “Fair Value Measurements and Disclosures”
defines fair value, the methods used to measure fair value and the
expanded disclosures about fair value measurements. Fair value is
the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between the buyer
and the seller at the measurement date. In determining fair value,
the valuation techniques consistent with the market approach,
income approach and cost approach shall be used to measure fair
value. FASB ASC Topic 820 establishes a fair value hierarchy for
inputs, which represent the assumptions used by the buyer and
seller in pricing the asset or liability. These inputs are further
defined as observable and unobservable inputs. Observable inputs
are those that buyer and seller would use in pricing the asset or
liability based on market data obtained from sources independent of
the Company. Unobservable inputs reflect the Company’s assumptions
about the inputs that the buyer and seller would use in pricing the
asset or liability developed based on the best information
available in the circumstances.
The fair value hierarchy is categorized into three levels based on
the inputs as follows:
Level
1 — |
Valuations based on unadjusted quoted prices in active markets for
identical assets or liabilities that the Company has the ability to
access. Valuation adjustments and block discounts are not being
applied. Since valuations are based on quoted prices that are
readily and regularly available in an active market, valuation of
these securities does not entail a significant degree of
judgment.
|
Level
2 — |
Valuations based on (i) quoted prices in active markets for similar
assets and liabilities, (ii) quoted prices in markets that are not
active for identical or similar assets, (iii) inputs other than
quoted prices for the assets or liabilities, or (iv) inputs that
are derived principally from or corroborated by market through
correlation or other means.
|
Level
3 — |
Valuations based on
inputs that are unobservable and significant to the overall fair
value measurement. |
The fair value of the Company’s certain assets and liabilities,
which qualify as financial instruments under ASC 820, “Fair
Value Measurements and Disclosures,” approximates the carrying
amounts represented in the balance sheet. The fair values of cash
and cash equivalents, and other current assets, accrued expenses,
due to sponsor are estimated to approximate the carrying values as
of June 30, 2021 due to the short maturities of such instruments.
See Note 9 for the disclosure of the Company’s assets and
liabilities that were measured at fair value on a recurring
basis.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
●Concentration of
credit risk
Financial instruments that potentially subject the Company to
concentration of credit risk consist of a cash account in a
financial institution. The Company has not experienced losses on
this account and management believes the Company is not exposed to
significant risks on such account.
● Income
taxes
Income taxes are determined in accordance with the provisions of
ASC Topic 740, “Income Taxes” (“ASC 740”). Under this
method, deferred tax assets and liabilities are recognized for the
future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and
liabilities and their respective tax basis. Deferred tax assets and
liabilities are measured using enacted income tax rates expected to
apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. Any effect on
deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that includes the enactment
date.
ASC 740 prescribes a comprehensive model for how companies should
recognize, measure, present, and disclose in their financial
statements uncertain tax positions taken or expected to be taken on
a tax return. Under ASC 740, tax positions must initially be
recognized in the financial statements when it is more likely than
not the position will be sustained upon examination by the tax
authorities. The Company’s management determined that the British
Virgin Islands is the Company’s major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized
tax benefits, if any, as income tax expense. There were no
unrecognized tax benefits and no amounts accrued for interest and
penalties as of June 30, 2021 or December 31, 2020. The Company is
currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its
position.
The Company may be subject to potential examination by foreign
taxing authorities in the area of income taxes. These potential
examinations may include questioning the timing and amount of
deductions, the nexus of income among various tax jurisdictions and
compliance with foreign tax laws.
The Company’s tax provision is zero for the period ended June 30,
2021.
The Company is considered to be an exempted British Virgin Islands
Company, and is presently not subject to income taxes or income tax
filing requirements in the British Virgin Islands or the United
States.
● Net loss
per share
The Company calculates net loss per share in accordance with ASC
Topic 260, Earnings per Share. In order to determine the net
income (loss) attributable to both the redeemable shares and
non-redeemable shares, the Company first considered the
undistributed income (loss) allocable to both the redeemable common
stock and non-redeemable common stock and the undistributed income
(loss) is calculated using the total net loss less any dividends
paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding
between the redeemable and non-redeemable common stock. Any
remeasurement of the accretion to redemption value of the common
stock subject to possible redemption was considered to be dividends
paid to the public stockholders. As of June 30, 2021, the Company
has not considered the effect of the warrants sold in the Initial
Public Offering to purchase an aggregate of 4,904,000 shares in the
calculation of diluted net loss per share, since the exercise of
the warrants is contingent upon the occurrence of future events and
the inclusion of such warrants would be anti-dilutive and the
Company did not have any other dilutive securities and other
contracts that could, potentially, be exercised or converted into
common stock and then share in the earnings of the Company. As a
result, diluted loss per share is the same as basic loss per share
for the period presented.
The net income (loss) per share presented in the unaudited
condensed statement of operations is based on the following:
|
|
For
the
Three Months
Ended
June 30, |
|
|
For
the
Six Months
Ended
June 30, |
|
|
|
2021 |
|
|
2021
|
|
Net loss |
|
$ |
(240,443 |
) |
|
$ |
(336,538 |
) |
Accretion of carrying value to
redemption value |
|
|
(5,014,797 |
) |
|
|
(5,014,797 |
) |
Net loss
including accretion of carrying value to redemption value |
|
$ |
(5,255,240 |
) |
|
$ |
(5,351,335 |
) |
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
|
|
For the Three Months Ended
September 30, 2021 |
|
|
For the Nine Months Ended
September 30, 2021 |
|
|
|
Redeemable
Common Stock |
|
|
Non-
Redeemable
Common Stock |
|
|
Redeemable Common Stock |
|
|
Non-Redeemable Common Stock |
|
Basic and diluted net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Numerators: |
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss including carrying value to redemption
value |
|
$ |
(3,911,528 |
) |
|
$ |
(1,343,712 |
) |
|
$ |
(3,307,548 |
) |
|
$ |
(2,043,787 |
) |
Accretion of carrying value to
redemption value |
|
|
5,014,797 |
|
|
|
-
|
|
|
|
5,014,797 |
|
|
|
-
|
|
Allocation of net
income (loss) |
|
$ |
1,103,269 |
|
|
$ |
(1,343,712 |
) |
|
$ |
1,707,249 |
|
|
$ |
(2,043,787 |
) |
Denominators: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares
outstanding |
|
|
4,145,055 |
|
|
|
1,423,934 |
|
|
|
2,083,978 |
|
|
|
1,287,724 |
|
Basic and diluted
net income (loss) per share |
|
$ |
0.27 |
|
|
$ |
(0.94 |
) |
|
$ |
0.82 |
|
|
$ |
(1.59 |
) |
●Related
parties
Parties, which can be a corporation or individual, are considered
to be related if the Company has the ability, directly or
indirectly, to control the other party or exercise significant
influence over the other party in making financial and operational
decisions. Companies are also considered to be related if they are
subject to common control or common significant influence.
● Recent
accounting pronouncements
The Company has considered all new accounting pronouncements and
has concluded that there are no new pronouncements that may have a
material impact on the results of operations, financial condition,
or cash flows, based on the current information.
NOTE 4 – CASH AND INVESTMENT HELD IN TRUST ACCOUNT
As of June 30, 2021, investment securities in the Company’s Trust
Account consisted of $46,921,322 in United States Treasury Bills
and $13 in cash. The Company classifies its United States Treasury
securities as available-for-sale. Available-for-sale marketable
securities are recorded at their estimated fair value on the
accompanying June 30, 2021 balance sheet. The carrying value,
including gross unrealized holding gain as other comprehensive
income and fair value of held to marketable securities on June 30,
2021 and December 31, 2020 is as follows:
|
|
Carrying
Value as of
June 30,
2021 (Unaudited) |
|
|
Gross
Unrealized Holding Gain |
|
|
Fair Value
as of
June 30,
2021 (Unaudited) |
|
Available-for-sale marketable
securities: |
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities |
|
$ |
46,921,322 |
|
|
$ |
-
|
|
|
$ |
46,921,322 |
|
NOTE 5 – PUBLIC OFFERING
On April 8, 2021, the Company sold 4,000,000 Public Units at a
price of $10.00 per Public Unit. On April 9, 2021, the Company sold
an additional 600,000 units to cover over-allotments. Each Public
Unit consists of one ordinary share and one redeemable warrant
(“Public Warrant”). Each Public Warrant entitles the holder to
purchase one ordinary share at an exercise price of $11.50 per
whole share (see Note 7).
The Company paid an upfront underwriting discount of $920,000,
equal to 2% of the gross offering proceeds to the underwriter at
the closing of the Initial Public Offering, with an additional fee
of $1,840,000 (the “Deferred Underwriting Discount”) or 4% of the
gross offering proceeds payable upon the Company’s completion of
the Business Combination. The Deferred Underwriting Discount will
become payable to the underwriter from the amounts held in the
Trust Account solely in the event the Company completes its
Business Combination. In the event that the Company does not close
the Business Combination, the underwriter has waived its right to
receive the Deferred Underwriting Discount. The underwriter is not
entitled to any interest accrued on the Deferred Underwriting
Discount.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 6 – PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the
Company consummated a private placement of 280,000 Private Units at
$10.00 per unit, purchased by the sponsor. On April 9, 2021, the
Company consummated an additional 24,000 units at $10.00 per unit
to cover over-allotments.
The Private Units are identical to the units sold in the Initial
Public Offering except that the warrants included in the Private
Units (the “Private Warrants”) are non-redeemable and may be
exercised on a cashless basis so long as the Private Warrants
continue to be held by the initial purchasers of the Placement
Units or their permitted transferees.
NOTE 7 – RELATED PARTY TRANSACTIONS
Founder Shares
In November 2020, the Company issued an aggregate of 1,000 founder
shares to the initial shareholders for an aggregate purchase price
of $1.
In December 2020, the Company issued an aggregate of 1,149,000
additional founder shares to the initial shareholders for an
aggregate purchase price of $24,999.
Advance from Related Parties
As of June 30, 2021, the Company had a temporary advance from a
shareholder and related party for its deferred cost of the Initial
Public Offering. The balance is unsecured, interest-free and has no
fixed terms of repayment.
Administrative Services Agreement
The Company is obligated, commencing from January 1, 2021, to pay
Ace Global Investment Limited a monthly fee of $10,000 for general
and administrative services. This agreement will terminate upon
completion of the Company’s business combination or the liquidation
of the trust account to public shareholders.
Related Party Extensions Loan
The Company will have until 12 months from the consummation of the
Initial Public Offering to consummate the initial Business
Combination. However, if the Company anticipates that the Company
may not be able to consummate the initial Business Combination
within 12 months, the Company may, but is not obligated to, extend
the period of time to consummate a Business Combination three times
by an additional three months each time (for a total of up to 21
months to complete a Business Combination). Pursuant to the terms
of our amended and restated memorandum and articles of association
and the trust agreement to be entered into between us and
Continental Stock Transfer & Trust Company, in order to extend
the time available for us to consummate our initial Business
Combination, the Company’s insiders or their affiliates or
designees, upon five days advance notice prior to the applicable
deadline, must deposit into the Trust Account $455,400 ($0.10 per
public share), on or prior to the date of the applicable deadline.
The insiders will receive a non-interest bearing, unsecured
promissory note equal to the amount of any such deposit that will
not be repaid in the event that the Company are unable to close a
Business Combination unless there are funds available outside the
Trust Account to do so. Such notes would either be paid upon
consummation of our initial Business Combination, or, at the
lender’s discretion, converted upon consummation of our Business
Combination into additional private units at a price of $10.00 per
unit.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 8 – SHAREHOLDER’S (DEFICIT) EQUITY
Ordinary shares
The Company is authorized to issue 100,000,000 ordinary shares at
par value of $0.001 per share. Holders of the Company’s ordinary
shares are entitled to one vote for each share.
On April 2021, the Company sold 4,600,000 units at a price of
$10.00 per Public Unit in the Public Offering.
In April, 2021, the Company issued 304,000 ordinary shares under
the private placement of 304,000 private units at $10 per unit, to
the Sponsor.
As of June 30, 2021 and December 31, 2021, 1,454,000 and 1,150,000
Ordinary Shares were issued and outstanding excluding 4,600,000 and
0 shares are subject to possible conversion.
Public Warrants
Each public warrant entitles the holder thereof to purchase
one-half (1/2) of one ordinary share at a price of $11.50 per full
share, subject to adjustment as described in this prospectus.
Pursuant to the warrant agreement, a warrant holder may exercise
its warrants only for a whole number of shares. This means that
only an even number of warrants may be exercised at any given time
by a warrant holder.
No public warrants will be exercisable for cash unless the Company
has an effective and current registration statement covering the
ordinary shares issuable upon exercise of the warrants and a
current prospectus relating to such ordinary shares. It is the
Company’s current intention to have an effective and current
registration statement covering the ordinary shares issuable upon
exercise of the warrants and a current prospectus relating to such
ordinary shares in effect promptly following consummation of an
initial business combination.
Notwithstanding the foregoing, if a registration statement covering
the ordinary shares issuable upon exercise of the public warrants
is not effective within 90 days following the consummation of our
initial business combination, public warrant holders may, until
such time as there is an effective registration statement and
during any period when we shall have failed to maintain an
effective registration statement, exercise warrants on a cashless
basis pursuant to an available exemption from registration under
the Securities Act. In such event, each holder would pay the
exercise price by surrendering the warrants for that number of
ordinary shares equal to the quotient obtained by dividing (x) the
product of the number of ordinary shares underlying the warrants,
multiplied by the difference between the exercise price of the
warrants and the “fair market value” (defined below) by (y) the
fair market value. The “fair market value” shall mean the average
reported last sale price of the ordinary shares for the 10 trading
days ending on the day prior to the date of exercise. For example,
if a holder held 300 warrants to purchase 150 shares and the fair
market value on the date prior to exercise was $15.00, that holder
would receive 35 shares without the payment of any additional cash
consideration. If an exemption from registration is not available,
holders will not be able to exercise their warrants on a cashless
basis.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The warrants will become exercisable on the later of the completion
of an initial business combination and March 31, 2022. The warrants
will expire at 5:00 p.m., New York City time, on the fifth
anniversary of our completion of an initial business combination,
or earlier upon redemption.
The Company may redeem the outstanding warrants (including any
outstanding warrants issued upon exercise of the unit purchase
option issued to Ladenburg Thalmann & Co., Inc.,), in whole and
not in part, at a price of $0.01 per warrant:
|
● |
at any time while the
Public Warrants are exercisable, |
|
● |
upon not less than
30 days’ prior written notice of redemption to each Public
Warrant holder, |
|
● |
if, and only if, the
reported last sale price of the ordinary shares equals or exceeds
$18.00 per share, for any 20 trading days within a 30 trading day
period ending on the third trading day prior to the notice of
redemption to Public Warrant holders, and |
|
● |
if, and only if, there
is a current registration statement in effect with respect to the
issuance of the ordinary shares underlying such warrants at the
time of redemption and for the entire 30-day trading period
referred to above and continuing each day thereafter until the date
of redemption. |
If the foregoing conditions are satisfied and the Company would
issue a notice of redemption, each warrant holder can exercise his,
her or its warrant prior to the scheduled redemption date. However,
the price of the ordinary shares may fall below the $18.00 trigger
price as well as the $11.50 warrant exercise price per full share
after the redemption notice is issued and not limit our ability to
complete the redemption.
The redemption criteria for the warrants have been established at a
price which is intended to provide warrant holders a reasonable
premium to the initial exercise price and provide a sufficient
differential between the then-prevailing share price and the
warrant exercise price so that if the share price declines as a
result of our redemption call, the redemption will not cause the
share price to drop below the exercise price of the warrants.
If the Company call the warrants for redemption as described above,
our management will have the option to require all holders that
wish to exercise warrants to do so on a “cashless basis.” In such
event, each holder would pay the exercise price by surrendering the
whole warrants for that number of ordinary shares equal to the
quotient obtained by dividing (x) the product of the number of
ordinary shares underlying the warrants, multiplied by the
difference between the exercise price of the warrants and the “fair
market value” (defined below) by (y) the fair market value. The
“fair market value” shall mean the average reported last sale price
of the ordinary shares for the 10 trading days ending on the third
trading day prior to the date on which the notice of redemption is
sent to the holders of warrants. Whether the Company will exercise
our option to require all holders to exercise their warrants on a
“cashless basis” will depend on a variety of factors including the
price of our ordinary shares at the time the warrants are called
for redemption, the Company’s cash needs at such time and concerns
regarding dilutive share issuances.
NOTE 9 – FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities
reflects management’s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in
connection with the transfer of the liabilities in an orderly
transaction between market participants at the measurement date. In
connection with measuring the fair value of its assets and
liabilities, the Company seeks to maximize the use of observable
inputs (market data obtained from independent sources) and to
minimize the use of unobservable inputs (internal assumptions about
how market participants would price assets and liabilities). The
following fair value hierarchy is used to classify assets and
liabilities based on the observable inputs and unobservable inputs
used in order to value the assets and liabilities:
Level 1: Quoted prices in active markets for identical assets or
liabilities. An active market for an asset or liability is a market
in which transactions for the asset or liability occur with
sufficient frequency and volume to provide pricing information on
an ongoing basis.
Level 2: Observable inputs other than Level 1 inputs. Examples of
Level 2 inputs include quoted prices in active markets for similar
assets or liabilities and quoted prices for identical assets or
liabilities in markets that are not active.
Level 3: Unobservable inputs based on our assessment of the
assumptions that market participants would use in pricing the asset
or liability.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The following table presents information about the Company’s assets
and liabilities that were measured at fair value on a recurring
basis as of June 30, 2021, and indicates the fair value hierarchy
of the valuation techniques the Company utilized to determine such
fair value.
|
|
June 30, |
|
|
Quoted Prices In
Active Markets |
|
|
Significant Other
Observable Inputs |
|
|
Significant
Other
Unobservable
Inputs |
|
Description |
|
2021 |
|
|
(Level
1) |
|
|
(Level
2) |
|
|
(Level
3) |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities held in Trust Account* |
|
$ |
46,921,335 |
|
|
$ |
46,921,335 |
|
|
$ |
-
|
|
|
$ |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities – Private Warrants |
|
$ |
1,250,000 |
|
|
$ |
-
|
|
|
$ |
-
|
|
|
$ |
1,250,000 |
|
|
* |
included in cash and investments
held in trust account on the Company’s balance sheet. |
The private warrants are accounted for as liabilities in accordance
with ASC 815-40 and are presented within warrant liabilities on the
consolidated balance sheets.
The Company established the initial fair value for the private
warrants at $1,258,560 on April 9, 2021, the date of the Company’s
Initial Public Offering, using a Black-Scholes model. The Company
allocated the proceeds received from the sale of Private Units,
first to the private warrants based on their fair values as
determined at initial measurement, with the remaining proceeds
recorded as ordinary shares subject to possible redemption, and
ordinary shares based on their relative fair values recorded at the
initial measurement date. The warrants were classified as Level 3
at the initial measurement date due to the use of unobservable
inputs.
The key inputs into the binomial model and Black-Scholes model were
as follows at their measurement dates:
|
|
June 30, 2021 |
|
|
April 9,
2021
(Initial measurement)
|
|
Input |
|
|
|
|
|
|
Share price |
|
$ |
10.05 |
|
|
$ |
10.00 |
|
Risk-free interest rate |
|
|
0.87 |
% |
|
|
0.87 |
% |
Volatility |
|
|
51 |
% |
|
|
52 |
% |
Exercise price |
|
$ |
11.50 |
|
|
$ |
11.50 |
|
Warrant life |
|
|
5 years |
|
|
|
5 years |
|
As of June 30, 2021, the aggregate value of the Private Warrants
was $1.25 million. The change in fair value from April 9, 2021 to
June 30, 2021 was approximately $(9,000).
To the extent that valuation is based on models or inputs that are
less observable or unobservable in the market, the determination of
fair value requires more judgment. Because of the inherent
uncertainty of valuation, those estimated values may be materially
higher or lower than the values that would have been used had a
ready market for the investments existed. Accordingly, the degree
of judgment exercised by the Company in determining fair value is
greatest for investments categorized in Level 3. Level 3 financial
liabilities consist of the Private Warrant liability for which
there is no current market for these securities such that the
determination of fair value requires significant judgment or
estimation. Changes in fair value measurements categorized within
Level 3 of the fair value hierarchy are analyzed each period based
on changes in estimates or assumptions and recorded as
appropriate.
ACE GLOBAL BUSINESS ACQUISITION LIMITED
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 10 – COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
Management is currently evaluating the impact of the COVID-19
pandemic on the industry and has concluded that while it is
reasonably possible that the virus could have a negative effect on
the Company’s future financial position, results of its operations
and/or search for a target company, there has been a significant
impact as of the date of these financial statements. The financial
statements do not include any adjustments that might result from
the future outcome of this uncertainty.
Registration Rights
The holders of the Founder Shares, the Private Warrants (and their
underlying securities) and the warrants that may be issued upon
conversion of the Working Capital Loans (and their underlying
securities) will be entitled to registration rights pursuant to a
registration rights agreement to be signed prior to or on the
effective date of the Initial Public Offering. The holders of a
majority of these securities will be entitled to make up to two
demands that the Company register such securities. The holders of
the majority of the Founder Shares can elect to exercise these
registration rights at any time commencing three months prior to
the date on which these ordinary shares are to be released from
escrow. The holders of a majority of the Private Warrants and
warrants issued in payment of Working Capital Loans made to the
Company (or underlying securities) can elect to exercise these
registration rights at any time after the Company consummates a
Business Combination. In addition, the holders will have certain
“piggy-back” registration rights with respect to registration
statements filed subsequent to the completion of a Business
Combination. The Company will bear the expenses incurred in
connection with the filing of any such registration statements.
Underwriter Agreement
The underwriters are entitled to a deferred fee of 4.0% of the
gross proceeds of the Initial Public Offering, or $1,840,000 until
the closing of the Business Combination. The deferred fee can be
paid in cash, stock or a combination of both (at the underwriter’s
discretion). Any stock issued as a part of the deferred fee will be
issued to the underwriters at the value per share in the Company’s
Trust Account, subject to any additional increases in the amount in
trust per the Company’s trust extensions. Stock to be issued to the
underwriters will have unlimited piggyback registration rights and
the same rights afforded other holders of the Company’s common
stock.
NOTE 11 – SUBSEQUENT EVENTS
On August 23, 2021, the Company, DDC Enterprise Limited (“DDC”) and
Ka Yin Norma Chu (as shareholders’ representative) entered into a
Share Exchange Agreement, pursuant to which the Company will
purchase from DDC’s shareholders all of the issued and outstanding
shares and other equity interests in and of DDC. Upon the closing
of the transactions contemplated in the Share Exchange Agreement,
Ace will acquire 100% of the issued and outstanding securities of
DDC, in exchange for approximately 30,000,000 of the Company’s
ordinary shares, among which 3,000,000 ordinary shares are to be
issued and held in escrow to satisfy any indemnification
obligations of the seller.
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or
the “Company” refer to Ace Global Acquisition Corporation.
References to our “management” or our “management team” refer to
our officers and directors, references to the “Sponsor” refer to
Ace Global Investment Limited. The following discussion and
analysis of the Company’s financial condition and results of
operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this
Quarterly Report. Certain information contained in the discussion
and analysis set forth below includes forward-looking statements
that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within
the meaning of Section 27A of the Securities Act and Section 21E of
the Exchange Act that are not historical facts and involve risks
and uncertainties that could cause actual results to differ
materially from those expected and projected. All statements, other
than statements of historical fact included in this Quarterly
Report including, without limitation, statements in this
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” regarding the Company’s financial position,
business strategy and the plans and objectives of management for
future operations, are forward-looking statements. Words such as
“expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and
variations and similar words and expressions are intended to
identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but
reflect management’s current beliefs, based on information
currently available. A number of factors could cause actual events,
performance or results to differ materially from the events,
performance and results discussed in the forward-looking
statements. For information identifying important factors that
could cause actual results to differ materially from those
anticipated in the forward-looking statements, please refer to the
Risk Factors section of the Registration Statement on Form S-1
(Registration No. 333-252878) filed with the SEC and declared
effective on April 5, 2021. The Company’s securities filings can be
accessed on the EDGAR section of the SEC’s website at www.sec.gov.
Except as expressly required by applicable securities law, the
Company disclaims any intention or obligation to update or revise
any forward-looking statements whether as a result of new
information, future events or otherwise.
Overview
We are a blank check company formed under the laws of the British
Virgin Islands on November 2, 2020 as a blank check company for the
purpose of engaging in a merger, share exchange, asset acquisition,
stock purchase, recapitalization, reorganization or other similar
business combination, with one or more target businesses or
entities. Our efforts to identify a prospective target business
will not be limited to a particular industry or geographic region,
although the Company intends to focus on operating businesses in
the gaming and e-commerce sectors in the Greater China, Japan and
Southeast Asia regions. We believe that we will add value to
these businesses primarily by providing them with access to the
U.S. capital markets.
On April 8, 2021, we consummated our initial public offering
(“IPO”) of 4,600,000 units (the “Units”), inclusive of the
over-allotment option of 600,000 Units. Each unit consisted of one
ordinary share, par value $0.001 and one redeemable warrant, upon
consummation of a business combination. The Company’s Registration
Statement on Form S-1 was declared effective by the SEC on April 5,
2021. Ladenburg Thalmann & Co., Inc., acted as an underwriter
for the IPO. The units were sold at an offering price of $10.00 per
unit, generating gross proceeds of $46,000,000.
Since our IPO, our sole business activity has been identifying and
evaluating suitable acquisition transaction candidates and engaging
in non-binding discussions with potential target entities. To date
we have not entered into any binding agreement with any target
entity. We presently have no revenue and have had losses since
inception from incurring formation and operating costs since
completion of our IPO.
We will seek to capitalize on the strength of our management team.
Our team consists of experienced professionals and senior operating
executives. Collectively, our officers and directors have decades
of experience in mergers and acquisitions, and operating companies,
in Asia. We believe we will benefit from their accomplishments, and
specifically their current and recent activities with companies
that have a connection to the Asian market, in identifying
attractive acquisition opportunities. However, there is no
assurance that we will complete a business combination.
We expect that we will issue additional equity securities or will
issue debt securities, or a combination of equity and debt
securities, in connection with the acquisition of a target
business. The issuance of additional shares of our stock in a
Business Combination:
|
● |
may significantly reduce
the equity interest of our stockholders; |
|
|
|
|
● |
may subordinate the
rights of holders of shares of common stock if we issue preference
shares with rights senior to those afforded to our shares of common
stock; |
|
|
|
|
● |
will likely cause a
change in control if a substantial number of our shares of common
stock are issued, which may affect, among other things, our ability
to use our net operating loss carry forwards, if any, and most
likely will also result in the resignation or removal of our
present officers and directors; and |
|
|
|
|
● |
may adversely affect
prevailing market prices for our securities. |
Similarly, if we issue debt securities or otherwise incur
significant indebtedness, it could result in:
|
● |
default and foreclosure
on our assets if our operating revenues after a business
combination are insufficient to pay our debt
obligations; |
|
|
|
|
● |
acceleration of our
obligations to repay the indebtedness even if we have made all
principal and interest payments when due if the debt security
contains covenants that required the maintenance of certain
financial ratios or reserves and we breach any such covenant
without a waiver or renegotiation of that covenant; |
|
|
|
|
● |
our immediate payment of
all principal and accrued interest, if any, if the debt security is
payable on demand; and |
|
|
|
|
● |
our inability to obtain
additional financing, if necessary, if the debt security contains
covenants restricting our ability to obtain additional financing
while such security is outstanding. |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly Report”) to “we,” “us” or
the “Company” refer to Venus Acquisition Corporation. References to
our “management” or our “management team” refer to our officers and
directors, references to the “Sponsor” refer to Yolanda Management
Corporation. The following discussion and analysis of the Company’s
financial condition and results of operations should be read in
conjunction with the financial statements and the notes thereto
contained elsewhere in this Quarterly Report. Certain information
contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and
uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Exchange Act that are not historical facts, and
involve risks and uncertainties that could cause actual results to
differ materially from those expected and projected. All
statements, other than statements of historical fact included in
this Form 10-Q including, without limitation, statements in this
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” regarding the Company’s financial position,
business strategy and the plans and objectives of management for
future operations, are forward-looking statements. Words such as
“expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and
variations and similar words and expressions are intended to
identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but
reflect management’s current beliefs, based on information
currently available. A number of factors could cause actual events,
performance or results to differ materially from the events,
performance and results discussed in the forward-looking
statements. For information identifying important factors that
could cause actual results to differ materially from those
anticipated in the forward-looking statements, please refer to the
Risk Factors section of the Company’s registration statement on
Form S-1 filed with the U.S. Securities and Exchange Commission
(the “SEC”). The Company’s securities filings can be accessed on
the EDGAR section of the SEC’s website at www.sec.gov. Except as
expressly required by applicable securities law, the Company
disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We were formed on November 2, 2020 formed under the laws of the
British Virgin Islands, as a blank check company for the purpose of
engaging in a merger, share exchange, asset acquisition, stock
purchase, recapitalization, reorganization or other similar
business combination, with one or more target businesses or
entities. Our efforts to identify a prospective target business
will not be limited to a particular industry or geographic region,
although we intend to focus on businesses that have a connection to
the Asian market. We believe that we will add value to these
businesses primarily by providing them with access to the U.S.
capital markets.
We presently have no revenue, have had losses since inception from
incurring formation costs and have had no operations other than the
active solicitation of a target business with which to complete a
business combination. We have relied upon the sale of our
securities and loans from our officers and directors to fund our
operations.
On April 8, 2021, the Company consummated the Initial Public
Offering of 4,000,000 ordinary units (the “Public Units”). Each
Public Unit consists of one ordinary share (“Ordinary Share”) and
one warrant (“Warrant”) entitling its holder to purchase one
Ordinary Share at a price of $11.50 per whole share. The Units were
sold at an offering price of $10.00 per Unit, generating gross
proceeds of $40,000,000.
Subsequently, on April 7, 2021, the underwriters exercised their
over-allotment option in full, and the closing of the issuance and
sale of the additional Public Units occurred on April 9, 2021. The
total aggregate issuance by the Company of 600,000 units at a price
of $10.00 per unit resulted in gross proceeds of $6,000,000.
Simultaneously with the closing of the Initial Public Offering on
April 8, 2021, the Company consummated the sale of 280,000 units
(the “Private Units”) at a price of $10.00 per Private Unit in a
private placement, generating gross proceeds of $2,800,000, which
is described in Note 4. On April 9, 2021, simultaneously with the
sale of the over-allotment units, the Company consummated the
private sale of an additional 24,000 Private Units, generating
gross proceeds of $240,000.
Transaction costs amounted to $1,125,000, consisting of $920,000 of
underwriter’s fees and $205,000 of other offering costs.
As a result of the IPO, the Private Placement and sale of units to
our underwriter, assuming the units were split into its component
parts, we had: (i) 4,904,000 units, (ii) 4,904,000 ordinary shares,
(iii) 4,904,000 warrants to acquire 4,904,000 ordinary shares
issued and outstanding as of April 9, 2021. We have not issued any
securities since such date.
Our management has broad discretion with respect to the specific
application of the net proceeds of the initial business combination
and the Private Placement, although substantially all of the net
proceeds are intended to be applied generally towards consummating
a business combination.
The outbreak of the COVID-19 coronavirus has resulted in a
widespread health crisis that has adversely affected the economies
and financial markets worldwide, and potential target companies may
defer or end discussions for a potential business combination with
us whether or not COVID-19 affects their business operations. The
extent to which COVID-19 impacts our search for a business
combination will depend on future developments, which are highly
uncertain and cannot be predicted, including new information which
may emerge concerning the severity of COVID-19 and the actions to
contain COVID-19 or treat its impact, among others. We may be
unable to complete a business combination if continued concerns
relating to COVID-19 restrict travel, limit the ability to have
meetings with potential investors or the target company’s
personnel, vendors and services providers are unavailable to
negotiate and consummate a transaction in a timely manner.
Results of Operations
Our entire activity from inception up to February 9, 2021 was in
preparation for the initial public offering. Since the initial
public offering, our activity has been limited to the evaluation of
business combination candidates, and we will not be generating any
operating revenues until the closing and completion of our initial
business combination. We expect to incur increased expenses as a
result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence
expenses. We expect our expenses to increase substantially after
this period.
For the three and six months ended June 30, 2021, we had a net loss
of $240,443 and $336,538, respectively, which was comprised of
interest and dividend income and general and administrative
expenses and a gain from change in fair value of warrant
liabilities.
Liquidity and Capital Resources
As of June 30, 2021, we had cash of $812,369. Until the
consummation of the initial public offering, the Company’s only
source of liquidity was an initial purchase of ordinary shares by
the Sponsor, monies loaned by the Sponsor under a certain unsecured
promissory note and advances from the Sponsor.
On April 8, 2021, the Company consummated its initial public
offering (“IPO”) of 4,000,000 units (the “Units”) and the full
exercise of the underwriter’s over-allotment option of 600,000
Units on April 9, 2021 respectively, Each Unit consists of one
ordinary share (“Ordinary Share”) and one warrant (“Warrant”)
entitling its holder to purchase one Ordinary Share at a price of
$11.50 per whole share. The Units were sold at an offering price of
$10.00 per Unit, generating gross proceeds of $46,000,000.
As of April 9, 2021, a total of $46,920,000 of the net proceeds
from the public offering and the private placement consummated
simultaneously with the closing of the IPO and the over-allotment
option were deposited in a trust account established for the
benefit of the Company’s public stockholders.
We intend to use substantially all of the net proceeds of the
initial public offering, including the funds held in the Trust
Account, to acquire a target business or businesses and to pay our
expenses relating thereto. To the extent that our capital stock is
used in whole or in part as consideration to effect our business
combination, the remaining proceeds held in the Trust Account, as
well as any other net proceeds not expended, will be used as
working capital to finance the operations of the target business.
Such working capital funds could be used in a variety of ways
including continuing or expanding the target business’ operations,
for strategic acquisitions and for marketing, research and
development of existing or new products. Such funds could also be
used to repay any operating expenses or finders’ fees which we had
incurred prior to the completion of our business combination if the
funds available to us outside of the Trust Account were
insufficient to cover such expenses.
We intend to use the funds held outside the Trust Account primarily
to identify and evaluate target businesses, perform business due
diligence on prospective target businesses, travel to and from the
offices, plants or similar locations of prospective target
businesses or their representatives or owners, review corporate
documents and material agreements of prospective target businesses,
and structure, negotiate and complete a business combination.
We do not believe we will need to raise additional funds in order
to meet the expenditures required for operating our business. This
belief is based on the fact that while we may begin preliminary due
diligence of a target business in connection with an indication of
interest, we intend to undertake in-depth due diligence, depending
on the circumstances of the relevant prospective acquisition, only
after we have negotiated and signed a letter of intent or other
preliminary agreement that addresses the terms of our initial
business combination. However, if our estimate of the costs of
undertaking in-depth due diligence and negotiating our initial
business combination is less than the actual amount necessary to do
so, or the amount of interest available to use from the trust
account is minimal as a result of the current interest rate
environment, we may be required to raise additional capital, the
amount, availability and cost of which is currently
unascertainable. In this event, we could seek such additional
capital through loans or additional investments from members of our
management team, but such members of our management team are not
under any obligation to advance funds to, or invest in, us. In the
event that the business combination does not close, we may use a
portion of the working capital held outside the Trust Account to
repay such loaned amounts, but no proceeds from our Trust Account
would be used for such repayment. Such loans would be evidenced by
promissory notes. The notes would either be paid upon consummation
of our business combination, without interest, or, at the lender’s
discretion, up to $500,000 of the notes may be converted upon
consummation of our business combination into additional Private
Units at a price of $10.00 per unit. The terms of such loans by our
initial shareholders, officers and directors, if any, have not been
determined and no written agreements exist with respect to such
loans.
Off-balance sheet financing arrangements
We have no obligations, assets or liabilities which would be
considered off-balance sheet arrangements as of June 30, 2021. We
do not participate in transactions that create relationships with
unconsolidated entities or financial partnerships, often referred
to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We
have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or
commitments of other entities, or purchased any non-financial
assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations,
operating lease obligations or long-term liabilities other than an
agreement to pay our Sponsor a monthly fee of $10,000 for general
and administrative services, including office space, utilities and
administrative services to the Company. We began incurring these
fees on February 8, 2021 and will continue to incur these fees
monthly until the earlier of the completion of the business
combination and the Company’s liquidation.
Registration Rights
The holders of our insider shares issued and outstanding prior to
our initial public offering, as well as the holders of the Private
Units (and all underlying securities) and any securities our
initial shareholders, officers, directors or their affiliates may
be issued in payment of working capital loans made to us, are
entitled to registration rights pursuant to a registration rights
agreement entered into concurrently without initial public
offering. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed
subsequent to our consummation of a business combination. We will
bear the expenses incurred in connection with the filing of any
such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred fee of 4.0% of the
gross proceeds of the Initial Public Offering, or $1,840,000 until
the closing of the Business Combination. The deferred fee can be
paid in cash, stock or a combination of both (at the underwriter’s
discretion). Any stock issued as a part of the deferred fee will be
issued to the underwriters at the value per share in the Company’s
Trust Account, subject to any additional increases in the amount in
trust per the Company’s trust extensions. Stock to be issued to the
underwriters will have unlimited piggyback registration rights and
the same rights afforded other holders of the Company’s common
stock.
Private Warrants
The Company classifies the Private Warrants as liabilities at their
fair value and adjusts the Private Warrants to fair value at each
reporting period. This liability is subject to re-measurement at
each balance sheet date until exercised, and any change in fair
value is recognized in our statement of operations. The Private
Warrants are valued using a Black Scholes model.
Critical Accounting Policies
The preparation of financial statements and related disclosures in
conformity with accounting principles generally accepted in the
United States of America (“GAAP”) requires management to make
estimates and assumptions that affect the reported amounts of
assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements, and income and
expenses during the periods reported. Actual results could
materially differ from those estimates. The Company has not
identified any significant accounting policies.
Ordinary Shares Subject To Possible Redemption
The Company accounts for its ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480
“Distinguishing Liabilities from Equity.” Ordinary share
subject to mandatory redemption (if any) is classified as a
liability instrument and is measured at fair value. Conditionally
redeemable ordinary shares (including ordinary shares that feature
redemption rights that are either within the control of the holder
or subject to redemption upon the occurrence of uncertain events
not solely within the Company’s control) are classified as
temporary equity. At all other times, ordinary shares are
classified as shareholders’ equity. The Company’s ordinary shares
feature certain redemption rights that are subject to occurrence of
uncertain future events and considered to be outside of the
Company’s control.
Net Income (Loss) Per Share
The Company calculates net income (loss) per share in accordance
with ASC Topic 260, “Earnings per Share.” Basic income
per share is computed by dividing the net income (loss) by the
weighted-average number of ordinary shares outstanding during the
period, excluding ordinary shares subject to possible conversion.
Diluted income (loss) per share is computed similar to basic income
(loss) per share except that the denominator is increased to
include the number of additional ordinary shares that would have
been outstanding if the potential ordinary share equivalents had
been issued and if the additional ordinary shares were dilutive.
Ordinary shares subject to possible conversion at the balance sheet
date, which are not currently redeemable and are not redeemable at
fair value, have been excluded from the calculation of basic and
diluted income (loss) per share since such shares, if redeemed,
only participate in their pro rata share of the Trust Account
earnings.
Warrant liabilities
The Company accounts for the Warrants in accordance with the
guidance contained in ASC 815-40-15-7D and 7F under which the
Private Warrants do not meet the criteria for equity treatment and
must be recorded as liabilities. Accordingly, the Company
classifies the Private Warrants as liabilities at their fair value
and adjusts the Private Warrants to fair value at each reporting
period. This liability is subject to re-measurement at each balance
sheet date until exercised, and any change in fair value is
recognized in our statement of operations. The Private Warrants are
valued using a Black Scholes model.
Item 3. Quantitative and Qualitative Disclosures About Market
Risk
As of June 30, 2021, we were not subject to any market or interest
rate risk. Following the consummation of our Initial Public
Offering, the net proceeds of our Initial Public Offering,
including amounts in the Trust Account, have been invested in U.S.
government treasury bills, notes or bonds with a maturity of 180
days or less or in certain money market funds that invest solely in
U.S. treasuries. Due to the short-term nature of these investments,
we believe there will be no associated material exposure to
interest rate risk.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our
Chief Executive Officer and Chief Financial Officer carried out an
evaluation of the effectiveness of the design and operation of our
disclosure controls and procedures as of June 30, 2021. In
connection with the preparation of this Form 10-Q, we revised our
prior position on accounting for private warrants. Based upon their
evaluation, and in light of the SEC Staff Statement, our Chief
Executive Officer and Chief Financial Officer concluded that our
disclosure controls and procedures (as defined in Rules 13a- 15 (e)
and 15d-15 (e) under the Exchange Act) were not effective as a
result of our revisions of our balance sheet as of April 9, 2021 to
reclassify our warrants accounting position and Public shares, as
well as the restatement for the temporary equity subject to
possible redemption, as described in the Explanatory Note to this
Amendment.
Restatement of Previously Issued Financial Statements
On May 19, 2021, we revised our prior position on accounting for
public and private warrants and concluded that our previously
issued balance as of April 9, 2021 should not be relied on because
of a misapplication in the guidance on warrant accounting. However,
the non-cash adjustments to the balance do not impact the amounts
previously reported for our cash and cash equivalents, and total
assets.
On June 30, 2021, we revisited our prior position on accounting for
public warrants and concluded that our public warrants as of April
9, 2021 should be reclassified as equity because of a
misapplication in the guidance on warrant accounting. However, the
non-cash adjustments to the balance do not impact the amounts
previously reported for our cash and cash equivalents, and total
assets.
In addition, the Company concluded it should restate its
financial statements to classify all ordinary shares subject to
possible redemption in temporary equity. In accordance with the SEC
and its staff’s guidance on redeemable equity instruments, ASC
Topic 480, Distinguishing Liabilities from
Equity (ASC 480), paragraph 10-S99, redemption provisions
not solely within the control of the Company require ordinary
shares subject to redemption to be classified outside of permanent
equity. The Company had previously classified a portion of its
ordinary shares in permanent equity. Although the Company did not
specify a maximum redemption threshold, its charter provides that
currently, the Company will not redeem its public shares in an
amount that would cause its net tangible assets to be less than
$5,000,001. The Company considered that the threshold would not
change the nature of the underlying shares as redeemable and thus
would be required to be disclosed outside equity. As a result, the
Company restated its previously filed financial statements to
classify all ordinary shares as temporary equity and to recognize
accretion from the initial book value to redemption value at the
time of its Initial Public Offering and in accordance with ASC 480.
The change in the carrying value of redeemable shares of ordinary
shares resulted in charges against additional paid-in capital and
accumulated deficit.
As a result, management identified these material weaknesses in our
internal control over financial reporting related to the accounting
for warrants and ordinary shares subject to possible
redemption.
To remediate these material weaknesses, we developed a remediation
plan with assistance from our accounting advisors and have
dedicated significant resources and efforts to the remediation and
improvement of our internal control over financial
reporting. While we have processes to identify and
appropriately apply applicable accounting requirements, we plan to
enhance our system of evaluating and implementing the complex
accounting standards that apply to our financial
statements. Our plans at this time include providing enhanced
access to accounting literature, research materials and documents
and increased communication among our personnel and third-party
professionals with whom we consult regarding complex accounting
applications. The elements of our remediation plan can only
be accomplished over time, and we can offer no assurance that these
initiatives will ultimately have the intended effects. For a
discussion of management’s consideration of the material weakness
identified related to our accounting for the public warrants and
redeemable shares we issued in connection with our initial public
offering, see “Note 2—Restatement of Previously Issued
Financial Statements” to the accompanying financial statements.
Changes in Internal Control over Financial Reporting
Other than the matter disclosed above, there was no change in our
internal control over financial reporting that occurred during the
fiscal quarter of June 30, 2021 covered by this Quarterly Report on
Form 10-Q/A that has materially affected, or is reasonably likely
to materially affect, our internal control over financial
reporting.
PART II - OTHER INFORMATION
Item 1A Legal Proceedings
The Company is not party to any legal proceedings as of the filing
date of this Form 10-Q/A.
Item 1A. Risk Factors.
Factors that could cause our actual results to differ materially
from those in this Quarterly Report are any of the risks described
in our final prospectus for our Initial Public Offering filed with
the SEC on April 5, 2021. Any of these factors could result in a
significant or material adverse effect on our results of operations
or financial condition. Additional risk factors not presently known
to us or that we currently deem immaterial may also impair our
business or results of operations. As of the date of this Quarterly
Report, there have been no material changes to the risk factors
disclosed in our final prospectus dated April 5, 2021 other than as
stated below.
Changes in the accounting treatment of the warrants issued in
out IPO and private warrants issued to our sponsor which may
require that the warrants be classified as equity and are
classified as a liability, we will have to incur significant
expense in valuing such liabilities on a quarterly and annual
basis, such liability would be reflected on our financial
statements, and such classification may make it more difficult for
us to complete an initial business combination.
On April 12, 2021, the staff of the SEC issued a public statement
entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants issued by Special Purpose Acquisition
Companies (“SPACs”). In the statement, the SEC staff expressed its
view that certain terms and conditions common to SPAC warrants may
require the warrants to be classified as liabilities on the SPAC’s
balance sheet as opposed to equity. If applicable, the warrants
should be classified as a liability measured at fair value, with
changes in fair value required to be reflected in the SPACs
quarterly and quarterly financial statements. It is possible that
our public warrants and private warrants would therefore be
classified as a liability. If we determine that our public warrants
and private warrants would be classified as liabilities, prior to
the effective date of the registration statement of which this
prospectus forms a part, we may amend the terms of the public
warrants and the private warrants in order that they may be
classified as equity, however, there can be no assurance that such
changes will result in the classification of the public warrants
and private warrants as equity. If the warrants are not classified
as equity and are classified as a liability, we will have to incur
significant expense in valuing such liabilities on a quarterly and
annual basis, such liability would be reflected on our financial
statements, and such classification and ongoing expense may make it
more difficult for us to complete an initial business
combination.
Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds.
On April 8, 2021, we consummated our initial public offering
(“IPO”) of 4,000,000 units (the “Units”). Subsequently, on April 7,
2021, the underwriters exercised the option in full, and the
closing of the issuance and sale of the additional Units occurred
on April 9, 2021. The total aggregate issuance by the Company of
4,600,000 units at a price of $10.00 per unit resulted in gross
proceeds of $46,000,000. Each unit consisted of one ordinary share,
par value $0.001, and one redeemable warrant. The Company’s
Registration Statement on Form S-1 was declared effective by the
SEC on April 5, 2021. Ladenburg Thalmann & Co., Inc., acted as
an underwriter for the IPO.
Simultaneously with the closing of the IPO on April 8, 2021, the
Company consummated the private placement (“Private Placement”)
with Ace Global Investment Limited, its sponsor, of 280,000 units
(the “Private Units”) at a price of $10.00 per Private Unit,
generating total proceeds of $2,800,000. On April 9, 2021,
simultaneously with the sale of the over-allotment units, the
Company consummated the private sale of an additional 24,000
Private Units, generating gross proceeds of $240,000. These
securities (other than our IPO securities) were issued pursuant to
an exemption from registration under the Securities Act of 1933, as
amended pursuant to Section 4(2) of the securities Act.
As of April 9, 2021, a total of $46,920,000 of the net proceeds
from the public offering and the private placement consummated
simultaneously with the closing of the IPO and the over-allotment
option were deposited in a trust account established for the
benefit of the Company’s public stockholders. The proceeds held in
the trust account may be invested by the trustee only in U.S.
government treasury bills with a maturity of 180 days or less or in
money market funds investing solely in U.S. government treasury
obligations and meeting certain conditions under Rule 2a-7 under
the Investment Company Act.
As a result of the IPO, the Private Placement and sale of units to
our underwriter, assuming the units were split into its component
parts, we had: (i) 4,904,000 units, (ii) 4,904,000 ordinary shares,
(iii) 4,904,000 warrants to acquire 4,904,000 ordinary shares
issued and outstanding as of April 9, 2021. We have not issued any
securities since such date.
We paid a total of $920,000 in underwriting discounts and
commissions (not including the 4.0% deferred underwriting
commission payable at the consummation of initial business
combination) and approximately $205,000 for other costs and
expenses related to our formation and the initial public
offering.
For a description of the use of the proceeds generated in our
Initial Public Offering, see Part I, Item 2 of this Form
10-Q/A.
Item 3. Defaults Upon Senior Securities.
None
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
None.
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by
reference into, this Quarterly Report on Form 10-Q/A.
|
(1) |
Previously filed as an exhibit to
our Current Report on Form 8-K filed on February 11, 2021 and
incorporated by reference herein. |
|
(2) |
Previously filed as an exhibit to
our Registration Statement on Form S-1 declared effective on
February 8, 2021. |
SIGNATURES
In accordance with the requirements of the Exchange Act, the
registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
ACE GLOBAL BUSINESS
ACQUISITION LIMITED |
|
|
|
Date December 21, 2021
|
By: |
/s/ Eugene
Wong |
|
Name: |
Eugene
Wong |
|
Title: |
Chief
Executive Officer |
|
|
(Principal Executive
Officer) |
|
|
|
Date:
December 21, 2021 |
By: |
/s/ Nicholas Xue Wei
Tan |
|
Name: |
Nicholas
Xue Wei Tan |
|
Title: |
Chief
Financial Officer |
|
|
(Principal Financial and
Accounting Officer) |
28
00-0000000 References throughout this
Amendment No. 1
 to the Quarterly Report on Form 10-Q/A to
“we,”
“us,” the
“Company” or “our
company” are
 to Ace Global Business
Acquisition Limited., unless the context otherwise indicates.This
Amendment No. 1 to the Quarterly Report on
 Form 10-Q/A
(this “report”) amends the Quarterly
Report on Form 10-Q of Ace Global Business Acquisition Limited for
the period
 ended June 30, 2021, as filed with the
Securities and Exchange Commission
(“SEC”) on August 16, 2021 (the
“Original
Report”).Background of RestatementOn April 12, 2021,
the Acting Director of the
 Division of Corporation Finance
and Acting Chief Accountant of the SEC together issued a statement
regarding the accounting and reporting
 considerations for
warrants issued by special purpose acquisition companies entitled
“Staff Statement on Accounting and
Reporting
 Considerations for Warrants Issued by Special
Purpose Acquisition
Companies(“SPACs”)”
(the “SEC Statement”).
Specifically, the SEC Statement focused on certain provisions that
provided for potential changes to the settlement amounts
dependent
 upon the characteristics of the holder of the
warrant, which terms are similar to those contained in the warrant
agreement governing the
 Company’s warrants.
As a result of the SEC Statement, on December 20, 2021, the Company
reevaluated the accounting treatment of
 the 4,600,000
warrants that were issued to the Company’s public
shareholders in a public offering that closed concurrently
with
 the closing of the Initial Public Offering (the
“Public Warrants”). The Company
previously accounted for the Public Warrants
 as components
of liabilities.As a result of the above, the Company should
have
 classified the Public warrants as component of equity
in its previously issued financial statements. The
Company’s accounting for
 the Public
warrants as components of equity instead of as derivative
liabilities did not have any effect on the Company’s
previously
 reported operating expenses or cash.In
addition, in accordance with the SEC and its
staff’s guidance on redeemable equity instruments,
ASC Topic 480, Distinguishing Liabilities from Equity (ASC 480),
paragraph
 10-S99, redemption provisions not solely within
the control of the Company require ordinary share subject to
redemption to be classified
 outside of permanent equity.
The Company had previously classified a portion of its ordinary
share in permanent equity. Although the Company
 did not
specify a maximum redemption threshold, its charter provides that
currently, the Company will not redeem its public shares
in
 an amount that would cause its net tangible assets to
be less than $5,000,001. On December 20, 2021, the Company
determined that the threshold
 would not change the nature
of the underlying shares as redeemable and thus would be required
to be disclosed outside equity. As a result,
 the
Company’s previously issued (i) audited balance
sheet as of April 9, 2021 included in the Company’s
Current Report on
 Form 8-K/A filed with the SEC on May 19,
2021, (ii) unaudited interim financial statements as of June 30,
2021 and for the three and six
 months ended June 30, 2021
included in the Company’s Quarterly Report on Form
10-Q filed with the SEC on August 16, 2021 (collectively,
the “Affected Periods”), in each
case, should be corrected to classify public warrants as equity and
all of the Public Shares
 as temporary equity and should no
longer be relied upon.In connection with the restatement, the
Company’s
 management reassessed the
effectiveness of its disclosure controls and procedures for the
periods affected by the restatement. As a result
 of that
reassessment, the Company’s management determined
that its disclosure controls and procedures for such periods were
not
 effective due to a material weakness in internal
control over financial reporting related to the classification of
the Company’s
 warrants as components of
equity instead of as derivative liabilities and the allocation and
treatment of the initial transaction costs
 of the initial
public offering. For more information, see Item 9A included in this
Quarterly Report on Form 10-Q/A.The Company has
reflected these corrections in
 its Quarterly Report on
Form 10-Q for the quarterly period ended September 30, 2021, filed
with SEC on November 16, 2021 (the
“November
 2021 Form 10-Q”)
and in this amended Quarterly Report on Form 10-Q/A for the period
ended September 30, 2021. The Company does not
 expect the
changes described above to have any impact on its cash position or
the balance held in the trust account. The Company has not
amended its previously filed Quarterly Reports on
Form 10-Q or Current Reports on Form 8-K
for the period affected by the restatement.
 The financial
information that has been previously filed or otherwise reported
for these periods is superseded by the information in this
interim Report on Form 10-Q/A, and the financial
statements and related financial information contained in such
previously filed
 reports should no longer be relied
upon.The restatement is more fully described in Note
 2 of
the notes to the financial statements included herein.Items Amended
in this ReportThis report presents the Original Report,
amended
 and restated with modifications necessary to
reflect the restatements, but without any other amendments,
modifications or updates. As
 such, this report speaks only
as of the date the Original Report was filed, and should be read in
conjunction with our other SEC filings,
 including our SEC
filings subsequent to the date of the Original Report.The following
items have been amended to reflect
 the restatements:Part
I, Item 1. Financial Statements And Supplementary
 DataPart
I, Item 2. Management’s Discussion
 and
Analysis of Financial Condition and Results of OperationsPart I,
Item 4. Controls and ProceduresIn addition, the
Company’s Chief Executive
 Officer and Chief
Financial Officer have provided new certifications dated as of the
date of this filing in connection with this report
(Exhibits 31.1, 31.2 and 32).Except as described above, this
Amendment No. 1
 does not amend, update or
change any other items or disclosures in the Original Filing and
does not purport to reflect any information
 or events
subsequent to the filing thereof. As such, this Amendment
No. 1 speaks only as of the date the Original Filing
was filed,
 and we have not undertaken herein to amend,
supplement or update any information contained in the Original
Filing to give effect to any
 subsequent events.
Accordingly, this Amendment No. 1 should be read in
conjunction with our filings made with the SEC subsequent
to the filing of the Original Filing, including any amendment to
those filings. true --12-31 Q2 N/A 0001844389 0001844389 2021-01-01
2021-06-30 0001844389 2021-11-11 0001844389 2021-06-30 0001844389
2020-12-31 0001844389 2021-04-01 2021-06-30 0001844389
us-gaap:CommonStockMember 2020-12-31 0001844389
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001844389
us-gaap:RetainedEarningsUnappropriatedMember 2020-12-31 0001844389
us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001844389
us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30
0001844389 us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01
2021-06-30 0001844389 us-gaap:CommonStockMember 2021-06-30
0001844389 us-gaap:AdditionalPaidInCapitalMember 2021-06-30
0001844389 us-gaap:RetainedEarningsUnappropriatedMember 2021-06-30
0001844389 us-gaap:CommonStockMember 2021-03-31 0001844389
us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001844389
us-gaap:RetainedEarningsUnappropriatedMember 2021-03-31 0001844389
2021-03-31 0001844389 us-gaap:CommonStockMember 2021-04-01
2021-06-30 0001844389 us-gaap:AdditionalPaidInCapitalMember
2021-04-01 2021-06-30 0001844389
us-gaap:RetainedEarningsUnappropriatedMember 2021-04-01 2021-06-30
0001844389 us-gaap:IPOMember 2021-04-08 0001844389 2021-04-08
0001844389 us-gaap:OverAllotmentOptionMember 2021-04-09 0001844389
2021-04-03 2021-04-09 0001844389 us-gaap:IPOMember 2021-06-30
0001844389 srt:ScenarioPreviouslyReportedMember 2021-04-09
0001844389 srt:RestatementAdjustmentMember 2021-04-09 0001844389
srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember
2021-04-09 0001844389 acba:AsRevisedMember 2021-04-09 0001844389
srt:ScenarioPreviouslyReportedMember
2021-06-30 0001844389 srt:RestatementAdjustmentMember 2021-06-30
0001844389
srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember
2021-06-30 0001844389 acba:AsRevisedMember 2021-06-30 0001844389
srt:ScenarioPreviouslyReportedMember 2021-04-01 2021-06-30
0001844389 srt:RestatementAdjustmentMember 2021-04-01 2021-06-30
0001844389
srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember
2021-04-01 2021-06-30 0001844389 acba:AsRevisedMember 2021-04-01
2021-06-30 0001844389 srt:ScenarioPreviouslyReportedMember
2021-01-01 2021-06-30 0001844389 srt:RestatementAdjustmentMember
2021-01-01 2021-06-30 0001844389
srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember
2021-01-01 2021-06-30 0001844389 acba:AsRevisedMember 2021-01-01
2021-06-30 0001844389 acba:RedeemableCommonStockMember 2021-04-01
2021-06-30 0001844389 acba:NonRedeemableCommonStockMember
2021-04-01 2021-06-30 0001844389 acba:RedeemableCommonStockMember
2021-01-01 2021-06-30 0001844389
acba:NonRedeemableCommonStockMember 2021-01-01 2021-06-30
0001844389 us-gaap:USTreasurySecuritiesMember 2021-06-30 0001844389
us-gaap:USTreasurySecuritiesMember 2021-01-01 2021-06-30 0001844389
acba:PublicUnitMember 2021-04-02 2021-04-08 0001844389
acba:PublicUnitMember 2021-04-08 0001844389 2021-04-09 0001844389
acba:PublicUnitMember 2021-01-01 2021-06-30 0001844389
us-gaap:PrivatePlacementMember 2021-01-01 2021-06-30 0001844389
us-gaap:PrivatePlacementMember 2021-06-30 0001844389
us-gaap:OverAllotmentOptionMember 2021-04-01 2021-04-09 0001844389
acba:FounderSharesMember 2020-11-30 0001844389
acba:FounderSharesMember 2020-12-31 0001844389 2020-12-28
2021-01-02 0001844389 us-gaap:IPOMember 2021-04-30 0001844389
2021-04-30 0001844389 us-gaap:PrivatePlacementMember 2021-04-30
0001844389 acba:SponsorMember 2021-04-01 2021-04-30 0001844389
2021-04-01 2021-04-09 0001844389
us-gaap:FairValueInputsLevel1Member 2021-06-30 0001844389
us-gaap:FairValueInputsLevel2Member 2021-06-30 0001844389
us-gaap:FairValueInputsLevel3Member 2021-06-30 0001844389
us-gaap:FairValueInputsLevel1Member 2021-01-01 2021-06-30
0001844389 us-gaap:FairValueInputsLevel2Member 2021-01-01
2021-06-30 0001844389 us-gaap:FairValueInputsLevel3Member
2021-01-01 2021-06-30 0001844389 us-gaap:SubsequentEventMember
2021-08-01 2021-08-23 0001844389 acba:DDCEnterpriseLimitedMember
us-gaap:SubsequentEventMember 2021-08-23 0001844389
us-gaap:SubsequentEventMember 2021-08-23 xbrli:shares iso4217:USD
iso4217:USD xbrli:shares xbrli:pure